id	sid	tid	token	lemma	pos
ajbspi-37630	1	1	volume	volume	NOUN
ajbspi-37630	1	2	03	03	NUM
ajbspi-37630	1	3	issue	issue	NOUN
ajbspi-37630	1	4	05	05	NUM
ajbspi-37630	1	5	-	-	SYM
ajbspi-37630	1	6	2023	2023	NUM
ajbspi-37630	1	7	1	1	NUM
ajbspi-37630	1	8	american	american	ADJ
ajbspi-37630	1	9	journal	journal	NOUN
ajbspi-37630	1	10	of	of	ADP
ajbspi-37630	1	11	biomedical	biomedical	PROPN
ajbspi-37630	1	12	science	science	PROPN
ajbspi-37630	1	13	&	&	CCONJ
ajbspi-37630	1	14	pharmaceutical	pharmaceutical	PROPN
ajbspi-37630	1	15	innovation	innovation	NOUN
ajbspi-37630	1	16	(	(	PUNCT
ajbspi-37630	1	17	issn	issn	PROPN
ajbspi-37630	1	18	–	–	PUNCT
ajbspi-37630	1	19	2771	2771	NUM
ajbspi-37630	1	20	-	-	SYM
ajbspi-37630	1	21	2753	2753	NUM
ajbspi-37630	1	22	)	)	PUNCT
ajbspi-37630	1	23	volume	volume	NOUN
ajbspi-37630	1	24	03	03	NUM
ajbspi-37630	1	25	issue	issue	NOUN
ajbspi-37630	1	26	05	05	NUM
ajbspi-37630	1	27	pages	page	NOUN
ajbspi-37630	1	28	:	:	PUNCT
ajbspi-37630	1	29	01	01	NUM
ajbspi-37630	1	30	-	-	PUNCT
ajbspi-37630	1	31	04	04	NUM
ajbspi-37630	1	32	sjif	sjif	NOUN
ajbspi-37630	1	33	impact	impact	NOUN
ajbspi-37630	1	34	factor	factor	NOUN
ajbspi-37630	1	35	(	(	PUNCT
ajbspi-37630	1	36	2021	2021	NUM
ajbspi-37630	1	37	:	:	PUNCT
ajbspi-37630	1	38	5	5	NUM
ajbspi-37630	1	39	.	.	NOUN
ajbspi-37630	1	40	705	705	NUM
ajbspi-37630	1	41	)	)	PUNCT
ajbspi-37630	1	42	(	(	PUNCT
ajbspi-37630	1	43	2022	2022	NUM
ajbspi-37630	1	44	:	:	PUNCT
ajbspi-37630	1	45	5	5	NUM
ajbspi-37630	1	46	.	.	NOUN
ajbspi-37630	1	47	705	705	NUM
ajbspi-37630	1	48	)	)	PUNCT
ajbspi-37630	1	49	(	(	PUNCT
ajbspi-37630	1	50	2023	2023	NUM
ajbspi-37630	1	51	:	:	PUNCT
ajbspi-37630	1	52	6.534	6.534	NUM
ajbspi-37630	1	53	)	)	PUNCT
ajbspi-37630	1	54	oclc	oclc	PROPN
ajbspi-37630	1	55	–	–	PUNCT
ajbspi-37630	1	56	1121105677	1121105677	NUM
ajbspi-37630	1	57	publisher	publisher	NOUN
ajbspi-37630	1	58	:	:	PUNCT
ajbspi-37630	1	59	oscar	oscar	NOUN
ajbspi-37630	1	60	publishing	publishing	NOUN
ajbspi-37630	1	61	services	service	NOUN
ajbspi-37630	1	62	servi	servi	ADJ
ajbspi-37630	1	63	abstract	abstract	ADJ
ajbspi-37630	1	64	fast	fast	ADV
ajbspi-37630	1	65	-	-	PUNCT
ajbspi-37630	1	66	dissolving	dissolve	VERB
ajbspi-37630	1	67	drugs	drug	NOUN
ajbspi-37630	1	68	have	have	AUX
ajbspi-37630	1	69	become	become	VERB
ajbspi-37630	1	70	increasingly	increasingly	ADV
ajbspi-37630	1	71	popular	popular	ADJ
ajbspi-37630	1	72	due	due	ADP
ajbspi-37630	1	73	to	to	ADP
ajbspi-37630	1	74	their	their	PRON
ajbspi-37630	1	75	convenience	convenience	NOUN
ajbspi-37630	1	76	and	and	CCONJ
ajbspi-37630	1	77	ease	ease	NOUN
ajbspi-37630	1	78	of	of	ADP
ajbspi-37630	1	79	administration	administration	NOUN
ajbspi-37630	1	80	,	,	PUNCT
ajbspi-37630	1	81	particularly	particularly	ADV
ajbspi-37630	1	82	for	for	ADP
ajbspi-37630	1	83	patients	patient	NOUN
ajbspi-37630	1	84	who	who	PRON
ajbspi-37630	1	85	have	have	VERB
ajbspi-37630	1	86	difficulty	difficulty	NOUN
ajbspi-37630	1	87	swallowing	swallow	VERB
ajbspi-37630	1	88	or	or	CCONJ
ajbspi-37630	1	89	require	require	VERB
ajbspi-37630	1	90	rapid	rapid	ADJ
ajbspi-37630	1	91	onset	onset	NOUN
ajbspi-37630	1	92	of	of	ADP
ajbspi-37630	1	93	action	action	NOUN
ajbspi-37630	1	94	.	.	PUNCT
ajbspi-37630	2	1	however	however	ADV
ajbspi-37630	2	2	,	,	PUNCT
ajbspi-37630	2	3	the	the	DET
ajbspi-37630	2	4	development	development	NOUN
ajbspi-37630	2	5	and	and	CCONJ
ajbspi-37630	2	6	formulation	formulation	NOUN
ajbspi-37630	2	7	of	of	ADP
ajbspi-37630	2	8	such	such	ADJ
ajbspi-37630	2	9	drugs	drug	NOUN
ajbspi-37630	2	10	can	can	AUX
ajbspi-37630	2	11	be	be	AUX
ajbspi-37630	2	12	challenging	challenge	VERB
ajbspi-37630	2	13	as	as	SCONJ
ajbspi-37630	2	14	they	they	PRON
ajbspi-37630	2	15	need	need	VERB
ajbspi-37630	2	16	to	to	PART
ajbspi-37630	2	17	maintain	maintain	VERB
ajbspi-37630	2	18	their	their	PRON
ajbspi-37630	2	19	stability	stability	NOUN
ajbspi-37630	2	20	and	and	CCONJ
ajbspi-37630	2	21	efficacy	efficacy	NOUN
ajbspi-37630	2	22	despite	despite	SCONJ
ajbspi-37630	2	23	the	the	DET
ajbspi-37630	2	24	accelerated	accelerate	VERB
ajbspi-37630	2	25	dissolution	dissolution	NOUN
ajbspi-37630	2	26	rate	rate	NOUN
ajbspi-37630	2	27	.	.	PUNCT
ajbspi-37630	3	1	in	in	ADP
ajbspi-37630	3	2	this	this	DET
ajbspi-37630	3	3	study	study	NOUN
ajbspi-37630	3	4	,	,	PUNCT
ajbspi-37630	3	5	we	we	PRON
ajbspi-37630	3	6	aimed	aim	VERB
ajbspi-37630	3	7	to	to	PART
ajbspi-37630	3	8	formulate	formulate	VERB
ajbspi-37630	3	9	and	and	CCONJ
ajbspi-37630	3	10	develop	develop	VERB
ajbspi-37630	3	11	a	a	DET
ajbspi-37630	3	12	fast	fast	ADV
ajbspi-37630	3	13	-	-	PUNCT
ajbspi-37630	3	14	dissolving	dissolve	VERB
ajbspi-37630	3	15	drug	drug	NOUN
ajbspi-37630	3	16	using	use	VERB
ajbspi-37630	3	17	a	a	DET
ajbspi-37630	3	18	novel	novel	ADJ
ajbspi-37630	3	19	approach	approach	NOUN
ajbspi-37630	3	20	and	and	CCONJ
ajbspi-37630	3	21	evaluate	evaluate	VERB
ajbspi-37630	3	22	its	its	PRON
ajbspi-37630	3	23	properties	property	NOUN
ajbspi-37630	3	24	and	and	CCONJ
ajbspi-37630	3	25	performance	performance	NOUN
ajbspi-37630	3	26	.	.	PUNCT
ajbspi-37630	4	1	we	we	PRON
ajbspi-37630	4	2	used	use	VERB
ajbspi-37630	4	3	a	a	DET
ajbspi-37630	4	4	combination	combination	NOUN
ajbspi-37630	4	5	of	of	ADP
ajbspi-37630	4	6	direct	direct	ADJ
ajbspi-37630	4	7	compression	compression	NOUN
ajbspi-37630	4	8	and	and	CCONJ
ajbspi-37630	4	9	freezedrying	freezedrye	VERB
ajbspi-37630	4	10	techniques	technique	NOUN
ajbspi-37630	4	11	to	to	PART
ajbspi-37630	4	12	formulate	formulate	VERB
ajbspi-37630	4	13	and	and	CCONJ
ajbspi-37630	4	14	develop	develop	VERB
ajbspi-37630	4	15	the	the	DET
ajbspi-37630	4	16	drug	drug	NOUN
ajbspi-37630	4	17	,	,	PUNCT
ajbspi-37630	4	18	with	with	ADP
ajbspi-37630	4	19	the	the	DET
ajbspi-37630	4	20	excipients	excipient	NOUN
ajbspi-37630	4	21	mannitol	mannitol	NOUN
ajbspi-37630	4	22	,	,	PUNCT
ajbspi-37630	4	23	crospovidone	crospovidone	NOUN
ajbspi-37630	4	24	,	,	PUNCT
ajbspi-37630	4	25	and	and	CCONJ
ajbspi-37630	4	26	microcrystalline	microcrystalline	NOUN
ajbspi-37630	4	27	cellulose	cellulose	NOUN
ajbspi-37630	4	28	.	.	PUNCT
ajbspi-37630	5	1	our	our	PRON
ajbspi-37630	5	2	optimized	optimize	VERB
ajbspi-37630	5	3	formulation	formulation	NOUN
ajbspi-37630	5	4	achieved	achieve	VERB
ajbspi-37630	5	5	a	a	DET
ajbspi-37630	5	6	disintegration	disintegration	NOUN
ajbspi-37630	5	7	time	time	NOUN
ajbspi-37630	5	8	of	of	ADP
ajbspi-37630	5	9	less	less	ADJ
ajbspi-37630	5	10	than	than	ADP
ajbspi-37630	5	11	30	30	NUM
ajbspi-37630	5	12	seconds	second	NOUN
ajbspi-37630	5	13	and	and	CCONJ
ajbspi-37630	5	14	a	a	DET
ajbspi-37630	5	15	dissolution	dissolution	ADJ
ajbspi-37630	5	16	rate	rate	NOUN
ajbspi-37630	5	17	of	of	ADP
ajbspi-37630	5	18	over	over	ADP
ajbspi-37630	5	19	90	90	NUM
ajbspi-37630	5	20	%	%	NOUN
ajbspi-37630	5	21	within	within	ADP
ajbspi-37630	5	22	2	2	NUM
ajbspi-37630	5	23	minutes	minute	NOUN
ajbspi-37630	5	24	.	.	PUNCT
ajbspi-37630	6	1	the	the	DET
ajbspi-37630	6	2	taste	taste	NOUN
ajbspi-37630	6	3	of	of	ADP
ajbspi-37630	6	4	the	the	DET
ajbspi-37630	6	5	drug	drug	NOUN
ajbspi-37630	6	6	was	be	AUX
ajbspi-37630	6	7	rated	rate	VERB
ajbspi-37630	6	8	as	as	ADP
ajbspi-37630	6	9	acceptable	acceptable	ADJ
ajbspi-37630	6	10	by	by	ADP
ajbspi-37630	6	11	the	the	DET
ajbspi-37630	6	12	majority	majority	NOUN
ajbspi-37630	6	13	of	of	ADP
ajbspi-37630	6	14	the	the	DET
ajbspi-37630	6	15	panelists	panelist	NOUN
ajbspi-37630	6	16	.	.	PUNCT
ajbspi-37630	7	1	stability	stability	NOUN
ajbspi-37630	7	2	testing	testing	NOUN
ajbspi-37630	7	3	showed	show	VERB
ajbspi-37630	7	4	that	that	SCONJ
ajbspi-37630	7	5	the	the	DET
ajbspi-37630	7	6	drug	drug	NOUN
ajbspi-37630	7	7	remained	remain	VERB
ajbspi-37630	7	8	effective	effective	ADJ
ajbspi-37630	7	9	and	and	CCONJ
ajbspi-37630	7	10	stable	stable	ADJ
ajbspi-37630	7	11	over	over	ADP
ajbspi-37630	7	12	a	a	DET
ajbspi-37630	7	13	period	period	NOUN
ajbspi-37630	7	14	of	of	ADP
ajbspi-37630	7	15	12	12	NUM
ajbspi-37630	7	16	months	month	NOUN
ajbspi-37630	7	17	,	,	PUNCT
ajbspi-37630	7	18	with	with	ADP
ajbspi-37630	7	19	no	no	DET
ajbspi-37630	7	20	significant	significant	ADJ
ajbspi-37630	7	21	degradation	degradation	NOUN
ajbspi-37630	7	22	or	or	CCONJ
ajbspi-37630	7	23	loss	loss	NOUN
ajbspi-37630	7	24	of	of	ADP
ajbspi-37630	7	25	potency	potency	NOUN
ajbspi-37630	7	26	.	.	PUNCT
ajbspi-37630	8	1	our	our	PRON
ajbspi-37630	8	2	study	study	NOUN
ajbspi-37630	8	3	demonstrates	demonstrate	VERB
ajbspi-37630	8	4	the	the	DET
ajbspi-37630	8	5	successful	successful	ADJ
ajbspi-37630	8	6	development	development	NOUN
ajbspi-37630	8	7	and	and	CCONJ
ajbspi-37630	8	8	formulation	formulation	NOUN
ajbspi-37630	8	9	of	of	ADP
ajbspi-37630	8	10	a	a	DET
ajbspi-37630	8	11	fast	fast	ADV
ajbspi-37630	8	12	-	-	PUNCT
ajbspi-37630	8	13	dissolving	dissolve	VERB
ajbspi-37630	8	14	drug	drug	NOUN
ajbspi-37630	8	15	using	use	VERB
ajbspi-37630	8	16	a	a	DET
ajbspi-37630	8	17	combination	combination	NOUN
ajbspi-37630	8	18	of	of	ADP
ajbspi-37630	8	19	direct	direct	ADJ
ajbspi-37630	8	20	compression	compression	NOUN
ajbspi-37630	8	21	and	and	CCONJ
ajbspi-37630	8	22	freeze	freeze	NOUN
ajbspi-37630	8	23	-	-	PUNCT
ajbspi-37630	8	24	drying	dry	VERB
ajbspi-37630	8	25	techniques	technique	NOUN
ajbspi-37630	8	26	,	,	PUNCT
ajbspi-37630	8	27	with	with	ADP
ajbspi-37630	8	28	promising	promising	ADJ
ajbspi-37630	8	29	results	result	NOUN
ajbspi-37630	8	30	in	in	ADP
ajbspi-37630	8	31	terms	term	NOUN
ajbspi-37630	8	32	of	of	ADP
ajbspi-37630	8	33	disintegration	disintegration	NOUN
ajbspi-37630	8	34	time	time	NOUN
ajbspi-37630	8	35	,	,	PUNCT
ajbspi-37630	8	36	dissolution	dissolution	NOUN
ajbspi-37630	8	37	rate	rate	NOUN
ajbspi-37630	8	38	,	,	PUNCT
ajbspi-37630	8	39	taste	taste	NOUN
ajbspi-37630	8	40	,	,	PUNCT
ajbspi-37630	8	41	and	and	CCONJ
ajbspi-37630	8	42	stability	stability	NOUN
ajbspi-37630	8	43	.	.	PUNCT
ajbspi-37630	9	1	keywords	keyword	VERB
ajbspi-37630	9	2	research	research	NOUN
ajbspi-37630	9	3	article	article	NOUN
ajbspi-37630	9	4	formulation	formulation	NOUN
ajbspi-37630	9	5	,	,	PUNCT
ajbspi-37630	9	6	development	development	NOUN
ajbspi-37630	9	7	,	,	PUNCT
ajbspi-37630	9	8	and	and	CCONJ
ajbspi-37630	9	9	evaluation	evaluation	NOUN
ajbspi-37630	9	10	of	of	ADP
ajbspi-37630	9	11	a	a	DET
ajbspi-37630	9	12	fastdissolving	fastdissolving	ADJ
ajbspi-37630	9	13	drug	drug	NOUN
ajbspi-37630	9	14	:	:	PUNCT
ajbspi-37630	9	15	a	a	DET
ajbspi-37630	9	16	novel	novel	ADJ
ajbspi-37630	9	17	approach	approach	NOUN
ajbspi-37630	9	18	submission	submission	NOUN
ajbspi-37630	9	19	date	date	NOUN
ajbspi-37630	9	20	:	:	PUNCT
ajbspi-37630	9	21	april	april	PROPN
ajbspi-37630	9	22	25	25	NUM
ajbspi-37630	9	23	,	,	PUNCT
ajbspi-37630	9	24	2023	2023	NUM
ajbspi-37630	9	25	,	,	PUNCT
ajbspi-37630	9	26	accepted	accept	VERB
ajbspi-37630	9	27	date	date	NOUN
ajbspi-37630	9	28	:	:	PUNCT
ajbspi-37630	9	29	april	april	PROPN
ajbspi-37630	9	30	30	30	NUM
ajbspi-37630	9	31	,	,	PUNCT
ajbspi-37630	9	32	2023	2023	NUM
ajbspi-37630	9	33	,	,	PUNCT
ajbspi-37630	9	34	published	publish	VERB
ajbspi-37630	9	35	date	date	NOUN
ajbspi-37630	9	36	:	:	PUNCT
ajbspi-37630	9	37	may	may	AUX
ajbspi-37630	9	38	01	01	NUM
ajbspi-37630	9	39	,	,	PUNCT
ajbspi-37630	9	40	2023	2023	NUM
ajbspi-37630	9	41	crossref	crossref	NOUN
ajbspi-37630	9	42	doi	doi	NOUN
ajbspi-37630	9	43	:	:	PUNCT
ajbspi-37630	9	44	https://doi.org/10.37547/ajbspi/volume03issue05-01	https://doi.org/10.37547/ajbspi/volume03issue05-01	PROPN
ajbspi-37630	9	45	aditya	aditya	PROPN
ajbspi-37630	9	46	sharma	sharma	PROPN
ajbspi-37630	9	47	arya	arya	PROPN
ajbspi-37630	9	48	college	college	PROPN
ajbspi-37630	9	49	of	of	ADP
ajbspi-37630	9	50	pharmacy	pharmacy	NOUN
ajbspi-37630	9	51	,	,	PUNCT
ajbspi-37630	9	52	jaipur	jaipur	PROPN
ajbspi-37630	9	53	,	,	PUNCT
ajbspi-37630	9	54	rajasthan	rajasthan	PROPN
ajbspi-37630	9	55	muhammad	muhammad	PROPN
ajbspi-37630	9	56	mehtab	mehtab	PROPN
ajbspi-37630	9	57	arya	arya	PROPN
ajbspi-37630	9	58	college	college	PROPN
ajbspi-37630	9	59	of	of	ADP
ajbspi-37630	9	60	pharmacy	pharmacy	NOUN
ajbspi-37630	9	61	,	,	PUNCT
ajbspi-37630	9	62	jaipur	jaipur	PROPN
ajbspi-37630	9	63	,	,	PUNCT
ajbspi-37630	9	64	rajasthan	rajasthan	PROPN
ajbspi-37630	9	65	journal	journal	NOUN
ajbspi-37630	9	66	website	website	NOUN
ajbspi-37630	9	67	:	:	PUNCT
ajbspi-37630	9	68	https://theusajournals	https://theusajournals	PROPN
ajbspi-37630	9	69	.	.	PUNCT
ajbspi-37630	9	70	com	com	NOUN
ajbspi-37630	9	71	/	/	SYM
ajbspi-37630	9	72	index.php	index.php	VERB
ajbspi-37630	9	73	/	/	SYM
ajbspi-37630	9	74	ajbspi	ajbspi	NOUN
ajbspi-37630	9	75	copyright	copyright	NOUN
ajbspi-37630	9	76	:	:	PUNCT
ajbspi-37630	9	77	original	original	ADJ
ajbspi-37630	9	78	content	content	NOUN
ajbspi-37630	9	79	from	from	ADP
ajbspi-37630	9	80	this	this	DET
ajbspi-37630	9	81	work	work	NOUN
ajbspi-37630	9	82	may	may	AUX
ajbspi-37630	9	83	be	be	AUX
ajbspi-37630	9	84	used	use	VERB
ajbspi-37630	9	85	under	under	ADP
ajbspi-37630	9	86	the	the	DET
ajbspi-37630	9	87	terms	term	NOUN
ajbspi-37630	9	88	of	of	ADP
ajbspi-37630	9	89	the	the	DET
ajbspi-37630	9	90	creative	creative	ADJ
ajbspi-37630	9	91	commons	common	NOUN
ajbspi-37630	9	92	attributes	attribute	VERB
ajbspi-37630	9	93	4.0	4.0	NUM
ajbspi-37630	9	94	licence	licence	NOUN
ajbspi-37630	9	95	.	.	PUNCT
ajbspi-37630	10	1	https://doi.org/10.37547/ajbspi/volume03issue03-01	https://doi.org/10.37547/ajbspi/volume03issue03-01	PROPN
ajbspi-37630	10	2	https://scholar.google.co.in/scholar?q=	https://scholar.google.co.in/scholar?q=	PROPN
ajbspi-37630	10	3	https://www.mendeley.com/search/?page=1&query=	https://www.mendeley.com/search/?page=1&query=	VERB
ajbspi-37630	10	4	https://theusajournals.com/	https://theusajournals.com/	ADJ
ajbspi-37630	10	5	https://doi.org/10.37547/ajbspi/volume03issue05-01	https://doi.org/10.37547/ajbspi/volume03issue05-01	ADJ
ajbspi-37630	10	6	https://theusajournals.com/index.php/ajbspi	https://theusajournals.com/index.php/ajbspi	NOUN
ajbspi-37630	10	7	https://theusajournals.com/index.php/ajbspi	https://theusajournals.com/index.php/ajbspi	NOUN
ajbspi-37630	10	8	volume	volume	NOUN
ajbspi-37630	10	9	03	03	NUM
ajbspi-37630	10	10	issue	issue	NOUN
ajbspi-37630	10	11	05	05	NUM
ajbspi-37630	10	12	-	-	SYM
ajbspi-37630	10	13	2023	2023	NUM
ajbspi-37630	10	14	2	2	NUM
ajbspi-37630	10	15	american	american	ADJ
ajbspi-37630	10	16	journal	journal	NOUN
ajbspi-37630	10	17	of	of	ADP
ajbspi-37630	10	18	biomedical	biomedical	PROPN
ajbspi-37630	10	19	science	science	PROPN
ajbspi-37630	10	20	&	&	CCONJ
ajbspi-37630	10	21	pharmaceutical	pharmaceutical	PROPN
ajbspi-37630	10	22	innovation	innovation	NOUN
ajbspi-37630	10	23	(	(	PUNCT
ajbspi-37630	10	24	issn	issn	PROPN
ajbspi-37630	10	25	–	–	PUNCT
ajbspi-37630	10	26	2771	2771	NUM
ajbspi-37630	10	27	-	-	SYM
ajbspi-37630	10	28	2753	2753	NUM
ajbspi-37630	10	29	)	)	PUNCT
ajbspi-37630	10	30	volume	volume	NOUN
ajbspi-37630	10	31	03	03	NUM
ajbspi-37630	10	32	issue	issue	NOUN
ajbspi-37630	10	33	05	05	NUM
ajbspi-37630	10	34	pages	page	NOUN
ajbspi-37630	10	35	:	:	PUNCT
ajbspi-37630	10	36	01	01	NUM
ajbspi-37630	10	37	-	-	PUNCT
ajbspi-37630	10	38	04	04	NUM
ajbspi-37630	10	39	sjif	sjif	NOUN
ajbspi-37630	10	40	impact	impact	NOUN
ajbspi-37630	10	41	factor	factor	NOUN
ajbspi-37630	10	42	(	(	PUNCT
ajbspi-37630	10	43	2021	2021	NUM
ajbspi-37630	10	44	:	:	PUNCT
ajbspi-37630	10	45	5	5	NUM
ajbspi-37630	10	46	.	.	NOUN
ajbspi-37630	10	47	705	705	NUM
ajbspi-37630	10	48	)	)	PUNCT
ajbspi-37630	10	49	(	(	PUNCT
ajbspi-37630	10	50	2022	2022	NUM
ajbspi-37630	10	51	:	:	PUNCT
ajbspi-37630	10	52	5	5	NUM
ajbspi-37630	10	53	.	.	NOUN
ajbspi-37630	10	54	705	705	NUM
ajbspi-37630	10	55	)	)	PUNCT
ajbspi-37630	10	56	(	(	PUNCT
ajbspi-37630	10	57	2023	2023	NUM
ajbspi-37630	10	58	:	:	PUNCT
ajbspi-37630	10	59	6.534	6.534	NUM
ajbspi-37630	10	60	)	)	PUNCT
ajbspi-37630	10	61	oclc	oclc	PROPN
ajbspi-37630	10	62	–	–	PUNCT
ajbspi-37630	10	63	1121105677	1121105677	NUM
ajbspi-37630	10	64	publisher	publisher	NOUN
ajbspi-37630	10	65	:	:	PUNCT
ajbspi-37630	10	66	oscar	oscar	NOUN
ajbspi-37630	10	67	publishing	publishing	NOUN
ajbspi-37630	10	68	services	service	NOUN
ajbspi-37630	10	69	servi	servi	ADJ
ajbspi-37630	10	70	fast	fast	ADV
ajbspi-37630	10	71	-	-	PUNCT
ajbspi-37630	10	72	dissolving	dissolve	VERB
ajbspi-37630	10	73	drug	drug	NOUN
ajbspi-37630	10	74	,	,	PUNCT
ajbspi-37630	10	75	direct	direct	ADJ
ajbspi-37630	10	76	compression	compression	NOUN
ajbspi-37630	10	77	,	,	PUNCT
ajbspi-37630	10	78	freeze	freeze	NOUN
ajbspi-37630	10	79	-	-	PUNCT
ajbspi-37630	10	80	drying	dry	VERB
ajbspi-37630	10	81	,	,	PUNCT
ajbspi-37630	10	82	disintegration	disintegration	NOUN
ajbspi-37630	10	83	time	time	NOUN
ajbspi-37630	10	84	,	,	PUNCT
ajbspi-37630	10	85	dissolution	dissolution	NOUN
ajbspi-37630	10	86	rate	rate	NOUN
ajbspi-37630	10	87	,	,	PUNCT
ajbspi-37630	10	88	stability	stability	NOUN
ajbspi-37630	10	89	testing	testing	NOUN
ajbspi-37630	10	90	,	,	PUNCT
ajbspi-37630	10	91	taste	taste	NOUN
ajbspi-37630	10	92	evaluation	evaluation	NOUN
ajbspi-37630	10	93	,	,	PUNCT
ajbspi-37630	10	94	recipients	recipient	NOUN
ajbspi-37630	10	95	.	.	PUNCT
ajbspi-37630	11	1	introduction	introduction	NOUN
ajbspi-37630	11	2	fast	fast	ADV
ajbspi-37630	11	3	-	-	PUNCT
ajbspi-37630	11	4	dissolving	dissolve	VERB
ajbspi-37630	11	5	drugs	drug	NOUN
ajbspi-37630	11	6	have	have	AUX
ajbspi-37630	11	7	become	become	VERB
ajbspi-37630	11	8	increasingly	increasingly	ADV
ajbspi-37630	11	9	popular	popular	ADJ
ajbspi-37630	11	10	due	due	ADP
ajbspi-37630	11	11	to	to	ADP
ajbspi-37630	11	12	their	their	PRON
ajbspi-37630	11	13	convenience	convenience	NOUN
ajbspi-37630	11	14	and	and	CCONJ
ajbspi-37630	11	15	ease	ease	NOUN
ajbspi-37630	11	16	of	of	ADP
ajbspi-37630	11	17	administration	administration	NOUN
ajbspi-37630	11	18	,	,	PUNCT
ajbspi-37630	11	19	particularly	particularly	ADV
ajbspi-37630	11	20	for	for	ADP
ajbspi-37630	11	21	patients	patient	NOUN
ajbspi-37630	11	22	who	who	PRON
ajbspi-37630	11	23	have	have	VERB
ajbspi-37630	11	24	difficulty	difficulty	NOUN
ajbspi-37630	11	25	swallowing	swallow	VERB
ajbspi-37630	11	26	or	or	CCONJ
ajbspi-37630	11	27	require	require	VERB
ajbspi-37630	11	28	rapid	rapid	ADJ
ajbspi-37630	11	29	onset	onset	NOUN
ajbspi-37630	11	30	of	of	ADP
ajbspi-37630	11	31	action	action	NOUN
ajbspi-37630	11	32	.	.	PUNCT
ajbspi-37630	12	1	however	however	ADV
ajbspi-37630	12	2	,	,	PUNCT
ajbspi-37630	12	3	the	the	DET
ajbspi-37630	12	4	development	development	NOUN
ajbspi-37630	12	5	and	and	CCONJ
ajbspi-37630	12	6	formulation	formulation	NOUN
ajbspi-37630	12	7	of	of	ADP
ajbspi-37630	12	8	such	such	ADJ
ajbspi-37630	12	9	drugs	drug	NOUN
ajbspi-37630	12	10	can	can	AUX
ajbspi-37630	12	11	be	be	AUX
ajbspi-37630	12	12	challenging	challenge	VERB
ajbspi-37630	12	13	as	as	SCONJ
ajbspi-37630	12	14	they	they	PRON
ajbspi-37630	12	15	need	need	VERB
ajbspi-37630	12	16	to	to	PART
ajbspi-37630	12	17	maintain	maintain	VERB
ajbspi-37630	12	18	their	their	PRON
ajbspi-37630	12	19	stability	stability	NOUN
ajbspi-37630	12	20	and	and	CCONJ
ajbspi-37630	12	21	efficacy	efficacy	NOUN
ajbspi-37630	12	22	despite	despite	SCONJ
ajbspi-37630	12	23	the	the	DET
ajbspi-37630	12	24	accelerated	accelerate	VERB
ajbspi-37630	12	25	dissolution	dissolution	NOUN
ajbspi-37630	12	26	rate	rate	NOUN
ajbspi-37630	12	27	.	.	PUNCT
ajbspi-37630	13	1	in	in	ADP
ajbspi-37630	13	2	this	this	DET
ajbspi-37630	13	3	study	study	NOUN
ajbspi-37630	13	4	,	,	PUNCT
ajbspi-37630	13	5	we	we	PRON
ajbspi-37630	13	6	aimed	aim	VERB
ajbspi-37630	13	7	to	to	PART
ajbspi-37630	13	8	formulate	formulate	VERB
ajbspi-37630	13	9	and	and	CCONJ
ajbspi-37630	13	10	develop	develop	VERB
ajbspi-37630	13	11	a	a	DET
ajbspi-37630	13	12	fast	fast	ADV
ajbspi-37630	13	13	-	-	PUNCT
ajbspi-37630	13	14	dissolving	dissolve	VERB
ajbspi-37630	13	15	drug	drug	NOUN
ajbspi-37630	13	16	using	use	VERB
ajbspi-37630	13	17	a	a	DET
ajbspi-37630	13	18	novel	novel	ADJ
ajbspi-37630	13	19	approach	approach	NOUN
ajbspi-37630	13	20	and	and	CCONJ
ajbspi-37630	13	21	evaluate	evaluate	VERB
ajbspi-37630	13	22	its	its	PRON
ajbspi-37630	13	23	properties	property	NOUN
ajbspi-37630	13	24	and	and	CCONJ
ajbspi-37630	13	25	performance	performance	NOUN
ajbspi-37630	13	26	.	.	PUNCT
ajbspi-37630	14	1	fast	fast	ADV
ajbspi-37630	14	2	-	-	PUNCT
ajbspi-37630	14	3	dissolving	dissolve	VERB
ajbspi-37630	14	4	drugs	drug	NOUN
ajbspi-37630	14	5	have	have	AUX
ajbspi-37630	14	6	gained	gain	VERB
ajbspi-37630	14	7	significant	significant	ADJ
ajbspi-37630	14	8	attention	attention	NOUN
ajbspi-37630	14	9	in	in	ADP
ajbspi-37630	14	10	recent	recent	ADJ
ajbspi-37630	14	11	years	year	NOUN
ajbspi-37630	14	12	due	due	ADP
ajbspi-37630	14	13	to	to	ADP
ajbspi-37630	14	14	their	their	PRON
ajbspi-37630	14	15	numerous	numerous	ADJ
ajbspi-37630	14	16	advantages	advantage	NOUN
ajbspi-37630	14	17	,	,	PUNCT
ajbspi-37630	14	18	including	include	VERB
ajbspi-37630	14	19	ease	ease	NOUN
ajbspi-37630	14	20	of	of	ADP
ajbspi-37630	14	21	administration	administration	NOUN
ajbspi-37630	14	22	,	,	PUNCT
ajbspi-37630	14	23	improved	improve	VERB
ajbspi-37630	14	24	patient	patient	ADJ
ajbspi-37630	14	25	compliance	compliance	NOUN
ajbspi-37630	14	26	,	,	PUNCT
ajbspi-37630	14	27	and	and	CCONJ
ajbspi-37630	14	28	rapid	rapid	ADJ
ajbspi-37630	14	29	onset	onset	NOUN
ajbspi-37630	14	30	of	of	ADP
ajbspi-37630	14	31	action	action	NOUN
ajbspi-37630	14	32	.	.	PUNCT
ajbspi-37630	15	1	these	these	DET
ajbspi-37630	15	2	drugs	drug	NOUN
ajbspi-37630	15	3	are	be	AUX
ajbspi-37630	15	4	particularly	particularly	ADV
ajbspi-37630	15	5	beneficial	beneficial	ADJ
ajbspi-37630	15	6	for	for	ADP
ajbspi-37630	15	7	patients	patient	NOUN
ajbspi-37630	15	8	who	who	PRON
ajbspi-37630	15	9	have	have	VERB
ajbspi-37630	15	10	difficulty	difficulty	NOUN
ajbspi-37630	15	11	swallowing	swallow	VERB
ajbspi-37630	15	12	tablets	tablet	NOUN
ajbspi-37630	15	13	or	or	CCONJ
ajbspi-37630	15	14	capsules	capsule	NOUN
ajbspi-37630	15	15	,	,	PUNCT
ajbspi-37630	15	16	such	such	ADJ
ajbspi-37630	15	17	as	as	ADP
ajbspi-37630	15	18	pediatric	pediatric	ADJ
ajbspi-37630	15	19	,	,	PUNCT
ajbspi-37630	15	20	geriatric	geriatric	ADJ
ajbspi-37630	15	21	,	,	PUNCT
ajbspi-37630	15	22	and	and	CCONJ
ajbspi-37630	15	23	dysphagic	dysphagic	NOUN
ajbspi-37630	15	24	patients	patient	NOUN
ajbspi-37630	15	25	.	.	PUNCT
ajbspi-37630	16	1	however	however	ADV
ajbspi-37630	16	2	,	,	PUNCT
ajbspi-37630	16	3	the	the	DET
ajbspi-37630	16	4	development	development	NOUN
ajbspi-37630	16	5	and	and	CCONJ
ajbspi-37630	16	6	formulation	formulation	NOUN
ajbspi-37630	16	7	of	of	ADP
ajbspi-37630	16	8	fast	fast	ADV
ajbspi-37630	16	9	-	-	PUNCT
ajbspi-37630	16	10	dissolving	dissolve	VERB
ajbspi-37630	16	11	drugs	drug	NOUN
ajbspi-37630	16	12	present	present	VERB
ajbspi-37630	16	13	significant	significant	ADJ
ajbspi-37630	16	14	challenges	challenge	NOUN
ajbspi-37630	16	15	,	,	PUNCT
ajbspi-37630	16	16	particularly	particularly	ADV
ajbspi-37630	16	17	with	with	ADP
ajbspi-37630	16	18	regard	regard	NOUN
ajbspi-37630	16	19	to	to	ADP
ajbspi-37630	16	20	maintaining	maintain	VERB
ajbspi-37630	16	21	stability	stability	NOUN
ajbspi-37630	16	22	,	,	PUNCT
ajbspi-37630	16	23	efficacy	efficacy	NOUN
ajbspi-37630	16	24	,	,	PUNCT
ajbspi-37630	16	25	and	and	CCONJ
ajbspi-37630	16	26	safety	safety	NOUN
ajbspi-37630	16	27	despite	despite	SCONJ
ajbspi-37630	16	28	the	the	DET
ajbspi-37630	16	29	accelerated	accelerate	VERB
ajbspi-37630	16	30	dissolution	dissolution	NOUN
ajbspi-37630	16	31	rate	rate	NOUN
ajbspi-37630	16	32	.	.	PUNCT
ajbspi-37630	17	1	various	various	ADJ
ajbspi-37630	17	2	techniques	technique	NOUN
ajbspi-37630	17	3	have	have	AUX
ajbspi-37630	17	4	been	be	AUX
ajbspi-37630	17	5	employed	employ	VERB
ajbspi-37630	17	6	to	to	PART
ajbspi-37630	17	7	develop	develop	VERB
ajbspi-37630	17	8	fast	fast	ADV
ajbspi-37630	17	9	-	-	PUNCT
ajbspi-37630	17	10	dissolving	dissolve	VERB
ajbspi-37630	17	11	drugs	drug	NOUN
ajbspi-37630	17	12	,	,	PUNCT
ajbspi-37630	17	13	including	include	VERB
ajbspi-37630	17	14	lyophilization	lyophilization	NOUN
ajbspi-37630	17	15	,	,	PUNCT
ajbspi-37630	17	16	direct	direct	ADJ
ajbspi-37630	17	17	compression	compression	NOUN
ajbspi-37630	17	18	,	,	PUNCT
ajbspi-37630	17	19	and	and	CCONJ
ajbspi-37630	17	20	spray	spray	NOUN
ajbspi-37630	17	21	-	-	PUNCT
ajbspi-37630	17	22	drying	dry	VERB
ajbspi-37630	17	23	.	.	PUNCT
ajbspi-37630	18	1	these	these	DET
ajbspi-37630	18	2	techniques	technique	NOUN
ajbspi-37630	18	3	often	often	ADV
ajbspi-37630	18	4	involve	involve	VERB
ajbspi-37630	18	5	the	the	DET
ajbspi-37630	18	6	use	use	NOUN
ajbspi-37630	18	7	of	of	ADP
ajbspi-37630	18	8	superdisintegrants	superdisintegrant	NOUN
ajbspi-37630	18	9	,	,	PUNCT
ajbspi-37630	18	10	which	which	PRON
ajbspi-37630	18	11	are	be	AUX
ajbspi-37630	18	12	excipients	excipient	NOUN
ajbspi-37630	18	13	that	that	PRON
ajbspi-37630	18	14	enhance	enhance	VERB
ajbspi-37630	18	15	the	the	DET
ajbspi-37630	18	16	dissolution	dissolution	NOUN
ajbspi-37630	18	17	rate	rate	NOUN
ajbspi-37630	18	18	of	of	ADP
ajbspi-37630	18	19	the	the	DET
ajbspi-37630	18	20	drug	drug	NOUN
ajbspi-37630	18	21	and	and	CCONJ
ajbspi-37630	18	22	promote	promote	VERB
ajbspi-37630	18	23	rapid	rapid	ADJ
ajbspi-37630	18	24	disintegration	disintegration	NOUN
ajbspi-37630	18	25	of	of	ADP
ajbspi-37630	18	26	the	the	DET
ajbspi-37630	18	27	tablet	tablet	NOUN
ajbspi-37630	18	28	or	or	CCONJ
ajbspi-37630	18	29	capsule	capsule	NOUN
ajbspi-37630	18	30	in	in	ADP
ajbspi-37630	18	31	the	the	DET
ajbspi-37630	18	32	oral	oral	ADJ
ajbspi-37630	18	33	cavity	cavity	NOUN
ajbspi-37630	18	34	.	.	PUNCT
ajbspi-37630	19	1	however	however	ADV
ajbspi-37630	19	2	,	,	PUNCT
ajbspi-37630	19	3	the	the	DET
ajbspi-37630	19	4	choice	choice	NOUN
ajbspi-37630	19	5	of	of	ADP
ajbspi-37630	19	6	excipients	excipient	NOUN
ajbspi-37630	19	7	and	and	CCONJ
ajbspi-37630	19	8	the	the	DET
ajbspi-37630	19	9	formulation	formulation	NOUN
ajbspi-37630	19	10	approach	approach	NOUN
ajbspi-37630	19	11	can	can	AUX
ajbspi-37630	19	12	significantly	significantly	ADV
ajbspi-37630	19	13	affect	affect	VERB
ajbspi-37630	19	14	the	the	DET
ajbspi-37630	19	15	properties	property	NOUN
ajbspi-37630	19	16	and	and	CCONJ
ajbspi-37630	19	17	performance	performance	NOUN
ajbspi-37630	19	18	of	of	ADP
ajbspi-37630	19	19	the	the	DET
ajbspi-37630	19	20	fast	fast	ADV
ajbspi-37630	19	21	-	-	PUNCT
ajbspi-37630	19	22	dissolving	dissolve	VERB
ajbspi-37630	19	23	drug	drug	NOUN
ajbspi-37630	19	24	.	.	PUNCT
ajbspi-37630	20	1	methods	method	NOUN
ajbspi-37630	20	2	we	we	PRON
ajbspi-37630	20	3	used	use	VERB
ajbspi-37630	20	4	a	a	DET
ajbspi-37630	20	5	combination	combination	NOUN
ajbspi-37630	20	6	of	of	ADP
ajbspi-37630	20	7	direct	direct	ADJ
ajbspi-37630	20	8	compression	compression	NOUN
ajbspi-37630	20	9	and	and	CCONJ
ajbspi-37630	20	10	freeze	freeze	NOUN
ajbspi-37630	20	11	-	-	PUNCT
ajbspi-37630	20	12	drying	dry	VERB
ajbspi-37630	20	13	techniques	technique	NOUN
ajbspi-37630	20	14	to	to	PART
ajbspi-37630	20	15	formulate	formulate	VERB
ajbspi-37630	20	16	and	and	CCONJ
ajbspi-37630	20	17	develop	develop	VERB
ajbspi-37630	20	18	a	a	DET
ajbspi-37630	20	19	fast	fast	ADV
ajbspi-37630	20	20	-	-	PUNCT
ajbspi-37630	20	21	dissolving	dissolve	VERB
ajbspi-37630	20	22	drug	drug	NOUN
ajbspi-37630	20	23	.	.	PUNCT
ajbspi-37630	21	1	the	the	DET
ajbspi-37630	21	2	excipients	excipient	NOUN
ajbspi-37630	21	3	used	use	VERB
ajbspi-37630	21	4	included	include	VERB
ajbspi-37630	21	5	mannitol	mannitol	NOUN
ajbspi-37630	21	6	,	,	PUNCT
ajbspi-37630	21	7	crospovidone	crospovidone	NOUN
ajbspi-37630	21	8	,	,	PUNCT
ajbspi-37630	21	9	and	and	CCONJ
ajbspi-37630	21	10	microcrystalline	microcrystalline	NOUN
ajbspi-37630	21	11	cellulose	cellulose	NOUN
ajbspi-37630	21	12	,	,	PUNCT
ajbspi-37630	21	13	which	which	PRON
ajbspi-37630	21	14	were	be	AUX
ajbspi-37630	21	15	chosen	choose	VERB
ajbspi-37630	21	16	based	base	VERB
ajbspi-37630	21	17	on	on	ADP
ajbspi-37630	21	18	their	their	PRON
ajbspi-37630	21	19	ability	ability	NOUN
ajbspi-37630	21	20	to	to	PART
ajbspi-37630	21	21	achieve	achieve	VERB
ajbspi-37630	21	22	the	the	DET
ajbspi-37630	21	23	desired	desire	VERB
ajbspi-37630	21	24	properties	property	NOUN
ajbspi-37630	21	25	of	of	ADP
ajbspi-37630	21	26	the	the	DET
ajbspi-37630	21	27	drug	drug	NOUN
ajbspi-37630	21	28	.	.	PUNCT
ajbspi-37630	22	1	we	we	PRON
ajbspi-37630	22	2	tested	test	VERB
ajbspi-37630	22	3	various	various	ADJ
ajbspi-37630	22	4	formulations	formulation	NOUN
ajbspi-37630	22	5	and	and	CCONJ
ajbspi-37630	22	6	optimized	optimize	VERB
ajbspi-37630	22	7	the	the	DET
ajbspi-37630	22	8	composition	composition	NOUN
ajbspi-37630	22	9	based	base	VERB
ajbspi-37630	22	10	on	on	ADP
ajbspi-37630	22	11	the	the	DET
ajbspi-37630	22	12	disintegration	disintegration	NOUN
ajbspi-37630	22	13	time	time	NOUN
ajbspi-37630	22	14	and	and	CCONJ
ajbspi-37630	22	15	dissolution	dissolution	NOUN
ajbspi-37630	22	16	rate	rate	NOUN
ajbspi-37630	22	17	.	.	PUNCT
ajbspi-37630	23	1	we	we	PRON
ajbspi-37630	23	2	also	also	ADV
ajbspi-37630	23	3	evaluated	evaluate	VERB
ajbspi-37630	23	4	the	the	DET
ajbspi-37630	23	5	taste	taste	NOUN
ajbspi-37630	23	6	of	of	ADP
ajbspi-37630	23	7	the	the	DET
ajbspi-37630	23	8	drug	drug	NOUN
ajbspi-37630	23	9	using	use	VERB
ajbspi-37630	23	10	a	a	DET
ajbspi-37630	23	11	panel	panel	NOUN
ajbspi-37630	23	12	of	of	ADP
ajbspi-37630	23	13	human	human	ADJ
ajbspi-37630	23	14	volunteers	volunteer	NOUN
ajbspi-37630	23	15	.	.	PUNCT
ajbspi-37630	24	1	finally	finally	ADV
ajbspi-37630	24	2	,	,	PUNCT
ajbspi-37630	24	3	we	we	PRON
ajbspi-37630	24	4	conducted	conduct	VERB
ajbspi-37630	24	5	stability	stability	NOUN
ajbspi-37630	24	6	testing	testing	NOUN
ajbspi-37630	24	7	to	to	PART
ajbspi-37630	24	8	ensure	ensure	VERB
ajbspi-37630	24	9	the	the	DET
ajbspi-37630	24	10	drug	drug	NOUN
ajbspi-37630	24	11	remained	remain	VERB
ajbspi-37630	24	12	effective	effective	ADJ
ajbspi-37630	24	13	and	and	CCONJ
ajbspi-37630	24	14	stable	stable	ADJ
ajbspi-37630	24	15	over	over	ADP
ajbspi-37630	24	16	time	time	NOUN
ajbspi-37630	24	17	.	.	PUNCT
ajbspi-37630	25	1	a.	a.	NOUN
ajbspi-37630	25	2	formulation	formulation	PROPN
ajbspi-37630	25	3	excipient	excipient	ADJ
ajbspi-37630	25	4	selection	selection	NOUN
ajbspi-37630	25	5	:	:	PUNCT
ajbspi-37630	25	6	mannitol	mannitol	NOUN
ajbspi-37630	25	7	,	,	PUNCT
ajbspi-37630	25	8	crospovidone	crospovidone	NOUN
ajbspi-37630	25	9	,	,	PUNCT
ajbspi-37630	25	10	and	and	CCONJ
ajbspi-37630	25	11	microcrystalline	microcrystalline	NOUN
ajbspi-37630	25	12	cellulose	cellulose	NOUN
ajbspi-37630	25	13	were	be	AUX
ajbspi-37630	25	14	selected	select	VERB
ajbspi-37630	25	15	as	as	ADP
ajbspi-37630	25	16	excipients	excipient	NOUN
ajbspi-37630	25	17	based	base	VERB
ajbspi-37630	25	18	on	on	ADP
ajbspi-37630	25	19	their	their	PRON
ajbspi-37630	25	20	ability	ability	NOUN
ajbspi-37630	25	21	to	to	PART
ajbspi-37630	25	22	achieve	achieve	VERB
ajbspi-37630	25	23	the	the	DET
ajbspi-37630	25	24	desired	desire	VERB
ajbspi-37630	25	25	properties	property	NOUN
ajbspi-37630	25	26	of	of	ADP
ajbspi-37630	25	27	the	the	DET
ajbspi-37630	25	28	fast	fast	ADV
ajbspi-37630	25	29	-	-	PUNCT
ajbspi-37630	25	30	dissolving	dissolve	VERB
ajbspi-37630	25	31	drug	drug	NOUN
ajbspi-37630	25	32	.	.	PUNCT
ajbspi-37630	26	1	preformulation	preformulation	NOUN
ajbspi-37630	26	2	studies	study	NOUN
ajbspi-37630	26	3	:	:	PUNCT
ajbspi-37630	26	4	preformulation	preformulation	NOUN
ajbspi-37630	26	5	studies	study	NOUN
ajbspi-37630	26	6	were	be	AUX
ajbspi-37630	26	7	conducted	conduct	VERB
ajbspi-37630	26	8	to	to	PART
ajbspi-37630	26	9	determine	determine	VERB
ajbspi-37630	26	10	the	the	DET
ajbspi-37630	26	11	compatibility	compatibility	NOUN
ajbspi-37630	26	12	of	of	ADP
ajbspi-37630	26	13	the	the	DET
ajbspi-37630	26	14	drug	drug	NOUN
ajbspi-37630	26	15	https://doi.org/10.37547/ajbspi/volume03issue03-01	https://doi.org/10.37547/ajbspi/volume03issue03-01	NOUN
ajbspi-37630	26	16	https://scholar.google.co.in/scholar?q=	https://scholar.google.co.in/scholar?q=	AUX
ajbspi-37630	26	17	https://www.mendeley.com/search/?page=1&query=	https://www.mendeley.com/search/?page=1&query=	ADJ
ajbspi-37630	26	18	volume	volume	NOUN
ajbspi-37630	26	19	03	03	NUM
ajbspi-37630	26	20	issue	issue	NOUN
ajbspi-37630	26	21	05	05	NUM
ajbspi-37630	26	22	-	-	SYM
ajbspi-37630	26	23	2023	2023	NUM
ajbspi-37630	26	24	3	3	NUM
ajbspi-37630	26	25	american	american	PROPN
ajbspi-37630	26	26	journal	journal	PROPN
ajbspi-37630	26	27	of	of	ADP
ajbspi-37630	26	28	biomedical	biomedical	PROPN
ajbspi-37630	26	29	science	science	PROPN
ajbspi-37630	26	30	&	&	CCONJ
ajbspi-37630	26	31	pharmaceutical	pharmaceutical	PROPN
ajbspi-37630	26	32	innovation	innovation	NOUN
ajbspi-37630	26	33	(	(	PUNCT
ajbspi-37630	26	34	issn	issn	PROPN
ajbspi-37630	26	35	–	–	PUNCT
ajbspi-37630	26	36	2771	2771	NUM
ajbspi-37630	26	37	-	-	SYM
ajbspi-37630	26	38	2753	2753	NUM
ajbspi-37630	26	39	)	)	PUNCT
ajbspi-37630	26	40	volume	volume	NOUN
ajbspi-37630	26	41	03	03	NUM
ajbspi-37630	26	42	issue	issue	NOUN
ajbspi-37630	26	43	05	05	NUM
ajbspi-37630	26	44	pages	page	NOUN
ajbspi-37630	26	45	:	:	PUNCT
ajbspi-37630	26	46	01	01	NUM
ajbspi-37630	26	47	-	-	PUNCT
ajbspi-37630	26	48	04	04	NUM
ajbspi-37630	26	49	sjif	sjif	NOUN
ajbspi-37630	26	50	impact	impact	NOUN
ajbspi-37630	26	51	factor	factor	NOUN
ajbspi-37630	26	52	(	(	PUNCT
ajbspi-37630	26	53	2021	2021	NUM
ajbspi-37630	26	54	:	:	PUNCT
ajbspi-37630	26	55	5	5	NUM
ajbspi-37630	26	56	.	.	NOUN
ajbspi-37630	26	57	705	705	NUM
ajbspi-37630	26	58	)	)	PUNCT
ajbspi-37630	26	59	(	(	PUNCT
ajbspi-37630	26	60	2022	2022	NUM
ajbspi-37630	26	61	:	:	PUNCT
ajbspi-37630	26	62	5	5	NUM
ajbspi-37630	26	63	.	.	NOUN
ajbspi-37630	26	64	705	705	NUM
ajbspi-37630	26	65	)	)	PUNCT
ajbspi-37630	26	66	(	(	PUNCT
ajbspi-37630	26	67	2023	2023	NUM
ajbspi-37630	26	68	:	:	PUNCT
ajbspi-37630	26	69	6.534	6.534	NUM
ajbspi-37630	26	70	)	)	PUNCT
ajbspi-37630	26	71	oclc	oclc	PROPN
ajbspi-37630	26	72	–	–	PUNCT
ajbspi-37630	26	73	1121105677	1121105677	NUM
ajbspi-37630	26	74	publisher	publisher	NOUN
ajbspi-37630	26	75	:	:	PUNCT
ajbspi-37630	26	76	oscar	oscar	NOUN
ajbspi-37630	26	77	publishing	publishing	NOUN
ajbspi-37630	26	78	services	service	NOUN
ajbspi-37630	26	79	servi	servi	VERB
ajbspi-37630	26	80	with	with	ADP
ajbspi-37630	26	81	the	the	DET
ajbspi-37630	26	82	selected	select	VERB
ajbspi-37630	26	83	excipients	excipient	NOUN
ajbspi-37630	26	84	,	,	PUNCT
ajbspi-37630	26	85	as	as	ADV
ajbspi-37630	26	86	well	well	ADV
ajbspi-37630	26	87	as	as	ADP
ajbspi-37630	26	88	to	to	PART
ajbspi-37630	26	89	assess	assess	VERB
ajbspi-37630	26	90	the	the	DET
ajbspi-37630	26	91	flow	flow	NOUN
ajbspi-37630	26	92	properties	property	NOUN
ajbspi-37630	26	93	of	of	ADP
ajbspi-37630	26	94	the	the	DET
ajbspi-37630	26	95	formulation	formulation	NOUN
ajbspi-37630	26	96	.	.	PUNCT
ajbspi-37630	27	1	formulation	formulation	NOUN
ajbspi-37630	27	2	development	development	NOUN
ajbspi-37630	27	3	:	:	PUNCT
ajbspi-37630	27	4	various	various	ADJ
ajbspi-37630	27	5	formulations	formulation	NOUN
ajbspi-37630	27	6	were	be	AUX
ajbspi-37630	27	7	developed	develop	VERB
ajbspi-37630	27	8	using	use	VERB
ajbspi-37630	27	9	different	different	ADJ
ajbspi-37630	27	10	ratios	ratio	NOUN
ajbspi-37630	27	11	of	of	ADP
ajbspi-37630	27	12	the	the	DET
ajbspi-37630	27	13	selected	select	VERB
ajbspi-37630	27	14	excipients	excipient	NOUN
ajbspi-37630	27	15	.	.	PUNCT
ajbspi-37630	28	1	the	the	DET
ajbspi-37630	28	2	formulations	formulation	NOUN
ajbspi-37630	28	3	were	be	AUX
ajbspi-37630	28	4	prepared	prepare	VERB
ajbspi-37630	28	5	by	by	ADP
ajbspi-37630	28	6	direct	direct	ADJ
ajbspi-37630	28	7	compression	compression	NOUN
ajbspi-37630	28	8	and	and	CCONJ
ajbspi-37630	28	9	freeze	freeze	NOUN
ajbspi-37630	28	10	-	-	PUNCT
ajbspi-37630	28	11	drying	dry	VERB
ajbspi-37630	28	12	techniques	technique	NOUN
ajbspi-37630	28	13	.	.	PUNCT
ajbspi-37630	29	1	optimization	optimization	NOUN
ajbspi-37630	29	2	:	:	PUNCT
ajbspi-37630	29	3	the	the	DET
ajbspi-37630	29	4	formulations	formulation	NOUN
ajbspi-37630	29	5	were	be	AUX
ajbspi-37630	29	6	optimized	optimize	VERB
ajbspi-37630	29	7	based	base	VERB
ajbspi-37630	29	8	on	on	ADP
ajbspi-37630	29	9	the	the	DET
ajbspi-37630	29	10	disintegration	disintegration	NOUN
ajbspi-37630	29	11	time	time	NOUN
ajbspi-37630	29	12	and	and	CCONJ
ajbspi-37630	29	13	dissolution	dissolution	NOUN
ajbspi-37630	29	14	rate	rate	NOUN
ajbspi-37630	29	15	.	.	PUNCT
ajbspi-37630	30	1	b.	b.	PROPN
ajbspi-37630	30	2	evaluation	evaluation	NOUN
ajbspi-37630	30	3	disintegration	disintegration	NOUN
ajbspi-37630	30	4	time	time	NOUN
ajbspi-37630	30	5	:	:	PUNCT
ajbspi-37630	30	6	the	the	DET
ajbspi-37630	30	7	disintegration	disintegration	NOUN
ajbspi-37630	30	8	time	time	NOUN
ajbspi-37630	30	9	of	of	ADP
ajbspi-37630	30	10	the	the	DET
ajbspi-37630	30	11	optimized	optimize	VERB
ajbspi-37630	30	12	formulation	formulation	NOUN
ajbspi-37630	30	13	was	be	AUX
ajbspi-37630	30	14	measured	measure	VERB
ajbspi-37630	30	15	using	use	VERB
ajbspi-37630	30	16	the	the	DET
ajbspi-37630	30	17	usp	usp	NOUN
ajbspi-37630	30	18	disintegration	disintegration	NOUN
ajbspi-37630	30	19	test	test	NOUN
ajbspi-37630	30	20	.	.	PUNCT
ajbspi-37630	31	1	dissolution	dissolution	NOUN
ajbspi-37630	31	2	rate	rate	NOUN
ajbspi-37630	31	3	:	:	PUNCT
ajbspi-37630	31	4	the	the	DET
ajbspi-37630	31	5	dissolution	dissolution	ADJ
ajbspi-37630	31	6	rate	rate	NOUN
ajbspi-37630	31	7	of	of	ADP
ajbspi-37630	31	8	the	the	DET
ajbspi-37630	31	9	optimized	optimize	VERB
ajbspi-37630	31	10	formulation	formulation	NOUN
ajbspi-37630	31	11	was	be	AUX
ajbspi-37630	31	12	measured	measure	VERB
ajbspi-37630	31	13	using	use	VERB
ajbspi-37630	31	14	the	the	DET
ajbspi-37630	31	15	usp	usp	NOUN
ajbspi-37630	31	16	dissolution	dissolution	PROPN
ajbspi-37630	31	17	test	test	NOUN
ajbspi-37630	31	18	.	.	PUNCT
ajbspi-37630	32	1	taste	taste	NOUN
ajbspi-37630	32	2	evaluation	evaluation	NOUN
ajbspi-37630	32	3	:	:	PUNCT
ajbspi-37630	32	4	a	a	DET
ajbspi-37630	32	5	panel	panel	NOUN
ajbspi-37630	32	6	of	of	ADP
ajbspi-37630	32	7	human	human	ADJ
ajbspi-37630	32	8	volunteers	volunteer	NOUN
ajbspi-37630	32	9	evaluated	evaluate	VERB
ajbspi-37630	32	10	the	the	DET
ajbspi-37630	32	11	taste	taste	NOUN
ajbspi-37630	32	12	of	of	ADP
ajbspi-37630	32	13	the	the	DET
ajbspi-37630	32	14	drug	drug	NOUN
ajbspi-37630	32	15	using	use	VERB
ajbspi-37630	32	16	a	a	DET
ajbspi-37630	32	17	5	5	NUM
ajbspi-37630	32	18	-	-	PUNCT
ajbspi-37630	32	19	point	point	NOUN
ajbspi-37630	32	20	hedonic	hedonic	ADJ
ajbspi-37630	32	21	scale	scale	NOUN
ajbspi-37630	32	22	.	.	PUNCT
ajbspi-37630	33	1	stability	stability	NOUN
ajbspi-37630	33	2	testing	testing	PROPN
ajbspi-37630	33	3	:	:	PUNCT
ajbspi-37630	33	4	the	the	DET
ajbspi-37630	33	5	stability	stability	NOUN
ajbspi-37630	33	6	of	of	ADP
ajbspi-37630	33	7	the	the	DET
ajbspi-37630	33	8	drug	drug	NOUN
ajbspi-37630	33	9	was	be	AUX
ajbspi-37630	33	10	evaluated	evaluate	VERB
ajbspi-37630	33	11	by	by	ADP
ajbspi-37630	33	12	storing	store	VERB
ajbspi-37630	33	13	the	the	DET
ajbspi-37630	33	14	optimized	optimize	VERB
ajbspi-37630	33	15	formulation	formulation	NOUN
ajbspi-37630	33	16	at	at	ADP
ajbspi-37630	33	17	different	different	ADJ
ajbspi-37630	33	18	temperatures	temperature	NOUN
ajbspi-37630	33	19	and	and	CCONJ
ajbspi-37630	33	20	humidity	humidity	NOUN
ajbspi-37630	33	21	conditions	condition	NOUN
ajbspi-37630	33	22	for	for	ADP
ajbspi-37630	33	23	12	12	NUM
ajbspi-37630	33	24	months	month	NOUN
ajbspi-37630	33	25	.	.	PUNCT
ajbspi-37630	34	1	the	the	DET
ajbspi-37630	34	2	drug	drug	NOUN
ajbspi-37630	34	3	was	be	AUX
ajbspi-37630	34	4	tested	test	VERB
ajbspi-37630	34	5	at	at	ADP
ajbspi-37630	34	6	various	various	ADJ
ajbspi-37630	34	7	time	time	NOUN
ajbspi-37630	34	8	points	point	NOUN
ajbspi-37630	34	9	for	for	ADP
ajbspi-37630	34	10	potency	potency	NOUN
ajbspi-37630	34	11	,	,	PUNCT
ajbspi-37630	34	12	disintegration	disintegration	NOUN
ajbspi-37630	34	13	time	time	NOUN
ajbspi-37630	34	14	,	,	PUNCT
ajbspi-37630	34	15	and	and	CCONJ
ajbspi-37630	34	16	dissolution	dissolution	ADJ
ajbspi-37630	34	17	rate	rate	NOUN
ajbspi-37630	34	18	.	.	PUNCT
ajbspi-37630	35	1	c.	c.	PROPN
ajbspi-37630	35	2	statistical	statistical	ADJ
ajbspi-37630	35	3	analysis	analysis	NOUN
ajbspi-37630	35	4	statistical	statistical	ADJ
ajbspi-37630	35	5	analysis	analysis	NOUN
ajbspi-37630	35	6	was	be	AUX
ajbspi-37630	35	7	performed	perform	VERB
ajbspi-37630	35	8	using	use	VERB
ajbspi-37630	35	9	anova	anova	PROPN
ajbspi-37630	35	10	and	and	CCONJ
ajbspi-37630	35	11	tukey	tukey	NOUN
ajbspi-37630	35	12	's	's	PART
ajbspi-37630	35	13	test	test	NOUN
ajbspi-37630	35	14	to	to	PART
ajbspi-37630	35	15	compare	compare	VERB
ajbspi-37630	35	16	the	the	DET
ajbspi-37630	35	17	disintegration	disintegration	NOUN
ajbspi-37630	35	18	time	time	NOUN
ajbspi-37630	35	19	and	and	CCONJ
ajbspi-37630	35	20	dissolution	dissolution	ADJ
ajbspi-37630	35	21	rate	rate	NOUN
ajbspi-37630	35	22	of	of	ADP
ajbspi-37630	35	23	the	the	DET
ajbspi-37630	35	24	different	different	ADJ
ajbspi-37630	35	25	formulations	formulation	NOUN
ajbspi-37630	35	26	.	.	PUNCT
ajbspi-37630	36	1	a	a	DET
ajbspi-37630	36	2	p	p	NOUN
ajbspi-37630	36	3	-	-	PUNCT
ajbspi-37630	36	4	value	value	NOUN
ajbspi-37630	36	5	of	of	ADP
ajbspi-37630	36	6	less	less	ADJ
ajbspi-37630	36	7	than	than	ADP
ajbspi-37630	36	8	0.05	0.05	NUM
ajbspi-37630	36	9	was	be	AUX
ajbspi-37630	36	10	considered	consider	VERB
ajbspi-37630	36	11	significant	significant	ADJ
ajbspi-37630	36	12	.	.	PUNCT
ajbspi-37630	37	1	results	result	VERB
ajbspi-37630	37	2	our	our	PRON
ajbspi-37630	37	3	optimized	optimize	VERB
ajbspi-37630	37	4	formulation	formulation	NOUN
ajbspi-37630	37	5	achieved	achieve	VERB
ajbspi-37630	37	6	a	a	DET
ajbspi-37630	37	7	disintegration	disintegration	NOUN
ajbspi-37630	37	8	time	time	NOUN
ajbspi-37630	37	9	of	of	ADP
ajbspi-37630	37	10	less	less	ADJ
ajbspi-37630	37	11	than	than	ADP
ajbspi-37630	37	12	30	30	NUM
ajbspi-37630	37	13	seconds	second	NOUN
ajbspi-37630	37	14	and	and	CCONJ
ajbspi-37630	37	15	a	a	DET
ajbspi-37630	37	16	dissolution	dissolution	ADJ
ajbspi-37630	37	17	rate	rate	NOUN
ajbspi-37630	37	18	of	of	ADP
ajbspi-37630	37	19	over	over	ADP
ajbspi-37630	37	20	90	90	NUM
ajbspi-37630	37	21	%	%	NOUN
ajbspi-37630	37	22	within	within	ADP
ajbspi-37630	37	23	2	2	NUM
ajbspi-37630	37	24	minutes	minute	NOUN
ajbspi-37630	37	25	.	.	PUNCT
ajbspi-37630	38	1	the	the	DET
ajbspi-37630	38	2	taste	taste	NOUN
ajbspi-37630	38	3	of	of	ADP
ajbspi-37630	38	4	the	the	DET
ajbspi-37630	38	5	drug	drug	NOUN
ajbspi-37630	38	6	was	be	AUX
ajbspi-37630	38	7	rated	rate	VERB
ajbspi-37630	38	8	as	as	ADP
ajbspi-37630	38	9	acceptable	acceptable	ADJ
ajbspi-37630	38	10	by	by	ADP
ajbspi-37630	38	11	the	the	DET
ajbspi-37630	38	12	majority	majority	NOUN
ajbspi-37630	38	13	of	of	ADP
ajbspi-37630	38	14	the	the	DET
ajbspi-37630	38	15	panelists	panelist	NOUN
ajbspi-37630	38	16	.	.	PUNCT
ajbspi-37630	39	1	stability	stability	NOUN
ajbspi-37630	39	2	testing	testing	NOUN
ajbspi-37630	39	3	showed	show	VERB
ajbspi-37630	39	4	that	that	SCONJ
ajbspi-37630	39	5	the	the	DET
ajbspi-37630	39	6	drug	drug	NOUN
ajbspi-37630	39	7	remained	remain	VERB
ajbspi-37630	39	8	effective	effective	ADJ
ajbspi-37630	39	9	and	and	CCONJ
ajbspi-37630	39	10	stable	stable	ADJ
ajbspi-37630	39	11	over	over	ADP
ajbspi-37630	39	12	a	a	DET
ajbspi-37630	39	13	period	period	NOUN
ajbspi-37630	39	14	of	of	ADP
ajbspi-37630	39	15	12	12	NUM
ajbspi-37630	39	16	months	month	NOUN
ajbspi-37630	39	17	,	,	PUNCT
ajbspi-37630	39	18	with	with	ADP
ajbspi-37630	39	19	no	no	DET
ajbspi-37630	39	20	significant	significant	ADJ
ajbspi-37630	39	21	degradation	degradation	NOUN
ajbspi-37630	39	22	or	or	CCONJ
ajbspi-37630	39	23	loss	loss	NOUN
ajbspi-37630	39	24	of	of	ADP
ajbspi-37630	39	25	potency	potency	NOUN
ajbspi-37630	39	26	.	.	PUNCT
ajbspi-37630	40	1	discussion	discussion	NOUN
ajbspi-37630	40	2	our	our	PRON
ajbspi-37630	40	3	study	study	NOUN
ajbspi-37630	40	4	demonstrates	demonstrate	VERB
ajbspi-37630	40	5	the	the	DET
ajbspi-37630	40	6	successful	successful	ADJ
ajbspi-37630	40	7	development	development	NOUN
ajbspi-37630	40	8	and	and	CCONJ
ajbspi-37630	40	9	formulation	formulation	NOUN
ajbspi-37630	40	10	of	of	ADP
ajbspi-37630	40	11	a	a	DET
ajbspi-37630	40	12	fast	fast	ADV
ajbspi-37630	40	13	-	-	PUNCT
ajbspi-37630	40	14	dissolving	dissolve	VERB
ajbspi-37630	40	15	drug	drug	NOUN
ajbspi-37630	40	16	using	use	VERB
ajbspi-37630	40	17	a	a	DET
ajbspi-37630	40	18	combination	combination	NOUN
ajbspi-37630	40	19	of	of	ADP
ajbspi-37630	40	20	direct	direct	ADJ
ajbspi-37630	40	21	compression	compression	NOUN
ajbspi-37630	40	22	and	and	CCONJ
ajbspi-37630	40	23	freeze	freeze	NOUN
ajbspi-37630	40	24	-	-	PUNCT
ajbspi-37630	40	25	drying	dry	VERB
ajbspi-37630	40	26	techniques	technique	NOUN
ajbspi-37630	40	27	.	.	PUNCT
ajbspi-37630	41	1	the	the	DET
ajbspi-37630	41	2	rapid	rapid	ADJ
ajbspi-37630	41	3	dissolution	dissolution	NOUN
ajbspi-37630	41	4	rate	rate	NOUN
ajbspi-37630	41	5	and	and	CCONJ
ajbspi-37630	41	6	acceptable	acceptable	ADJ
ajbspi-37630	41	7	taste	taste	NOUN
ajbspi-37630	41	8	make	make	VERB
ajbspi-37630	41	9	it	it	PRON
ajbspi-37630	41	10	a	a	DET
ajbspi-37630	41	11	promising	promising	ADJ
ajbspi-37630	41	12	option	option	NOUN
ajbspi-37630	41	13	for	for	ADP
ajbspi-37630	41	14	patients	patient	NOUN
ajbspi-37630	41	15	who	who	PRON
ajbspi-37630	41	16	have	have	VERB
ajbspi-37630	41	17	difficulty	difficulty	NOUN
ajbspi-37630	41	18	swallowing	swallow	VERB
ajbspi-37630	41	19	or	or	CCONJ
ajbspi-37630	41	20	require	require	VERB
ajbspi-37630	41	21	rapid	rapid	ADJ
ajbspi-37630	41	22	onset	onset	NOUN
ajbspi-37630	41	23	of	of	ADP
ajbspi-37630	41	24	action	action	NOUN
ajbspi-37630	41	25	.	.	PUNCT
ajbspi-37630	42	1	the	the	DET
ajbspi-37630	42	2	optimized	optimize	VERB
ajbspi-37630	42	3	formulation	formulation	NOUN
ajbspi-37630	42	4	achieved	achieve	VERB
ajbspi-37630	42	5	a	a	DET
ajbspi-37630	42	6	disintegration	disintegration	NOUN
ajbspi-37630	42	7	time	time	NOUN
ajbspi-37630	42	8	and	and	CCONJ
ajbspi-37630	42	9	dissolution	dissolution	NOUN
ajbspi-37630	42	10	rate	rate	NOUN
ajbspi-37630	42	11	that	that	PRON
ajbspi-37630	42	12	meet	meet	VERB
ajbspi-37630	42	13	the	the	DET
ajbspi-37630	42	14	requirements	requirement	NOUN
ajbspi-37630	42	15	of	of	ADP
ajbspi-37630	42	16	fast	fast	ADV
ajbspi-37630	42	17	-	-	PUNCT
ajbspi-37630	42	18	dissolving	dissolve	VERB
ajbspi-37630	42	19	drugs	drug	NOUN
ajbspi-37630	42	20	,	,	PUNCT
ajbspi-37630	42	21	which	which	PRON
ajbspi-37630	42	22	is	be	AUX
ajbspi-37630	42	23	essential	essential	ADJ
ajbspi-37630	42	24	for	for	ADP
ajbspi-37630	42	25	ensuring	ensure	VERB
ajbspi-37630	42	26	the	the	DET
ajbspi-37630	42	27	efficacy	efficacy	NOUN
ajbspi-37630	42	28	of	of	ADP
ajbspi-37630	42	29	the	the	DET
ajbspi-37630	42	30	drug	drug	NOUN
ajbspi-37630	42	31	.	.	PUNCT
ajbspi-37630	43	1	the	the	DET
ajbspi-37630	43	2	stability	stability	NOUN
ajbspi-37630	43	3	testing	testing	NOUN
ajbspi-37630	43	4	results	result	NOUN
ajbspi-37630	43	5	demonstrate	demonstrate	VERB
ajbspi-37630	43	6	that	that	SCONJ
ajbspi-37630	43	7	the	the	DET
ajbspi-37630	43	8	drug	drug	NOUN
ajbspi-37630	43	9	remains	remain	VERB
ajbspi-37630	43	10	stable	stable	ADJ
ajbspi-37630	43	11	and	and	CCONJ
ajbspi-37630	43	12	effective	effective	ADJ
ajbspi-37630	43	13	over	over	ADP
ajbspi-37630	43	14	an	an	DET
ajbspi-37630	43	15	extended	extended	ADJ
ajbspi-37630	43	16	period	period	NOUN
ajbspi-37630	43	17	,	,	PUNCT
ajbspi-37630	43	18	which	which	PRON
ajbspi-37630	43	19	is	be	AUX
ajbspi-37630	43	20	crucial	crucial	ADJ
ajbspi-37630	43	21	for	for	ADP
ajbspi-37630	43	22	ensuring	ensure	VERB
ajbspi-37630	43	23	the	the	DET
ajbspi-37630	43	24	quality	quality	NOUN
ajbspi-37630	43	25	of	of	ADP
ajbspi-37630	43	26	the	the	DET
ajbspi-37630	43	27	drug	drug	NOUN
ajbspi-37630	43	28	.	.	PUNCT
ajbspi-37630	44	1	conclusion	conclusion	NOUN
ajbspi-37630	44	2	in	in	ADP
ajbspi-37630	44	3	conclusion	conclusion	NOUN
ajbspi-37630	44	4	,	,	PUNCT
ajbspi-37630	44	5	the	the	DET
ajbspi-37630	44	6	novel	novel	ADJ
ajbspi-37630	44	7	approach	approach	NOUN
ajbspi-37630	44	8	we	we	PRON
ajbspi-37630	44	9	used	use	VERB
ajbspi-37630	44	10	to	to	PART
ajbspi-37630	44	11	formulate	formulate	VERB
ajbspi-37630	44	12	and	and	CCONJ
ajbspi-37630	44	13	develop	develop	VERB
ajbspi-37630	44	14	a	a	DET
ajbspi-37630	44	15	fast	fast	ADV
ajbspi-37630	44	16	-	-	PUNCT
ajbspi-37630	44	17	dissolving	dissolve	VERB
ajbspi-37630	44	18	drug	drug	NOUN
ajbspi-37630	44	19	has	have	AUX
ajbspi-37630	44	20	shown	show	VERB
ajbspi-37630	44	21	promising	promising	ADJ
ajbspi-37630	44	22	results	result	NOUN
ajbspi-37630	44	23	in	in	ADP
ajbspi-37630	44	24	terms	term	NOUN
ajbspi-37630	44	25	of	of	ADP
ajbspi-37630	44	26	disintegration	disintegration	NOUN
ajbspi-37630	44	27	time	time	NOUN
ajbspi-37630	44	28	,	,	PUNCT
ajbspi-37630	44	29	dissolution	dissolution	NOUN
ajbspi-37630	44	30	rate	rate	NOUN
ajbspi-37630	44	31	,	,	PUNCT
ajbspi-37630	44	32	taste	taste	NOUN
ajbspi-37630	44	33	,	,	PUNCT
ajbspi-37630	44	34	and	and	CCONJ
ajbspi-37630	44	35	stability	stability	NOUN
ajbspi-37630	44	36	.	.	PUNCT
ajbspi-37630	45	1	future	future	ADJ
ajbspi-37630	45	2	research	research	NOUN
ajbspi-37630	45	3	could	could	AUX
ajbspi-37630	45	4	focus	focus	VERB
ajbspi-37630	45	5	on	on	ADP
ajbspi-37630	45	6	optimizing	optimize	VERB
ajbspi-37630	45	7	the	the	DET
ajbspi-37630	45	8	formulation	formulation	NOUN
ajbspi-37630	45	9	for	for	ADP
ajbspi-37630	45	10	specific	specific	ADJ
ajbspi-37630	45	11	drug	drug	NOUN
ajbspi-37630	45	12	classes	class	NOUN
ajbspi-37630	45	13	or	or	CCONJ
ajbspi-37630	45	14	patient	patient	ADJ
ajbspi-37630	45	15	populations	population	NOUN
ajbspi-37630	45	16	,	,	PUNCT
ajbspi-37630	45	17	as	as	ADV
ajbspi-37630	45	18	well	well	ADV
ajbspi-37630	45	19	as	as	ADP
ajbspi-37630	45	20	exploring	explore	VERB
ajbspi-37630	45	21	the	the	DET
ajbspi-37630	45	22	use	use	NOUN
ajbspi-37630	45	23	of	of	ADP
ajbspi-37630	45	24	alternative	alternative	ADJ
ajbspi-37630	45	25	excipients	excipient	NOUN
ajbspi-37630	45	26	or	or	CCONJ
ajbspi-37630	45	27	https://doi.org/10.37547/ajbspi/volume03issue03-01	https://doi.org/10.37547/ajbspi/volume03issue03-01	NOUN
ajbspi-37630	45	28	https://scholar.google.co.in/scholar?q=	https://scholar.google.co.in/scholar?q=	NOUN
ajbspi-37630	45	29	https://www.mendeley.com/search/?page=1&query=	https://www.mendeley.com/search/?page=1&query=	ADJ
ajbspi-37630	45	30	volume	volume	NOUN
ajbspi-37630	45	31	03	03	NUM
ajbspi-37630	45	32	issue	issue	NOUN
ajbspi-37630	45	33	05	05	NUM
ajbspi-37630	45	34	-	-	SYM
ajbspi-37630	45	35	2023	2023	NUM
ajbspi-37630	45	36	4	4	NUM
ajbspi-37630	45	37	american	american	ADJ
ajbspi-37630	45	38	journal	journal	NOUN
ajbspi-37630	45	39	of	of	ADP
ajbspi-37630	45	40	biomedical	biomedical	PROPN
ajbspi-37630	45	41	science	science	PROPN
ajbspi-37630	45	42	&	&	CCONJ
ajbspi-37630	45	43	pharmaceutical	pharmaceutical	PROPN
ajbspi-37630	45	44	innovation	innovation	NOUN
ajbspi-37630	45	45	(	(	PUNCT
ajbspi-37630	45	46	issn	issn	PROPN
ajbspi-37630	45	47	–	–	PUNCT
ajbspi-37630	45	48	2771	2771	NUM
ajbspi-37630	45	49	-	-	SYM
ajbspi-37630	45	50	2753	2753	NUM
ajbspi-37630	45	51	)	)	PUNCT
ajbspi-37630	46	1	volume	volume	NOUN
ajbspi-37630	46	2	03	03	NUM
ajbspi-37630	46	3	issue	issue	NOUN
ajbspi-37630	46	4	05	05	NUM
ajbspi-37630	46	5	pages	page	NOUN
ajbspi-37630	46	6	:	:	PUNCT
ajbspi-37630	46	7	01	01	NUM
ajbspi-37630	46	8	-	-	PUNCT
ajbspi-37630	46	9	04	04	NUM
ajbspi-37630	46	10	sjif	sjif	NOUN
ajbspi-37630	46	11	impact	impact	NOUN
ajbspi-37630	46	12	factor	factor	NOUN
ajbspi-37630	46	13	(	(	PUNCT
ajbspi-37630	46	14	2021	2021	NUM
ajbspi-37630	46	15	:	:	PUNCT
ajbspi-37630	46	16	5	5	NUM
ajbspi-37630	46	17	.	.	NOUN
ajbspi-37630	46	18	705	705	NUM
ajbspi-37630	46	19	)	)	PUNCT
ajbspi-37630	46	20	(	(	PUNCT
ajbspi-37630	46	21	2022	2022	NUM
ajbspi-37630	46	22	:	:	PUNCT
ajbspi-37630	46	23	5	5	NUM
ajbspi-37630	46	24	.	.	NOUN
ajbspi-37630	46	25	705	705	NUM
ajbspi-37630	46	26	)	)	PUNCT
ajbspi-37630	46	27	(	(	PUNCT
ajbspi-37630	46	28	2023	2023	NUM
ajbspi-37630	46	29	:	:	PUNCT
ajbspi-37630	46	30	6.534	6.534	NUM
ajbspi-37630	46	31	)	)	PUNCT
ajbspi-37630	46	32	oclc	oclc	PROPN
ajbspi-37630	46	33	–	–	PUNCT
ajbspi-37630	46	34	1121105677	1121105677	NUM
ajbspi-37630	46	35	publisher	publisher	NOUN
ajbspi-37630	46	36	:	:	PUNCT
ajbspi-37630	46	37	oscar	oscar	NOUN
ajbspi-37630	46	38	publishing	publishing	NOUN
ajbspi-37630	46	39	services	service	NOUN
ajbspi-37630	46	40	servi	servi	ADJ
ajbspi-37630	46	41	manufacturing	manufacturing	NOUN
ajbspi-37630	46	42	techniques	technique	NOUN
ajbspi-37630	46	43	to	to	PART
ajbspi-37630	46	44	further	far	ADV
ajbspi-37630	46	45	enhance	enhance	VERB
ajbspi-37630	46	46	the	the	DET
ajbspi-37630	46	47	drug	drug	NOUN
ajbspi-37630	46	48	's	's	PART
ajbspi-37630	46	49	performance	performance	NOUN
ajbspi-37630	46	50	.	.	PUNCT
ajbspi-37630	47	1	references	reference	NOUN
ajbspi-37630	47	2	1	1	NUM
ajbspi-37630	47	3	.	.	PUNCT
ajbspi-37630	47	4	aungst	aungst	PROPN
ajbspi-37630	47	5	,	,	PUNCT
ajbspi-37630	47	6	b.	b.	PROPN
ajbspi-37630	47	7	j.	j.	PROPN
ajbspi-37630	47	8	(	(	PUNCT
ajbspi-37630	47	9	2000	2000	NUM
ajbspi-37630	47	10	)	)	PUNCT
ajbspi-37630	47	11	.	.	PUNCT
ajbspi-37630	48	1	novel	novel	ADJ
ajbspi-37630	48	2	formulation	formulation	NOUN
ajbspi-37630	48	3	strategies	strategy	NOUN
ajbspi-37630	48	4	for	for	ADP
ajbspi-37630	48	5	improving	improve	VERB
ajbspi-37630	48	6	oral	oral	ADJ
ajbspi-37630	48	7	bioavailability	bioavailability	NOUN
ajbspi-37630	48	8	of	of	ADP
ajbspi-37630	48	9	drugs	drug	NOUN
ajbspi-37630	48	10	with	with	ADP
ajbspi-37630	48	11	poor	poor	ADJ
ajbspi-37630	48	12	membrane	membrane	NOUN
ajbspi-37630	48	13	permeation	permeation	NOUN
ajbspi-37630	48	14	or	or	CCONJ
ajbspi-37630	48	15	presystemic	presystemic	ADJ
ajbspi-37630	48	16	metabolism	metabolism	NOUN
ajbspi-37630	48	17	.	.	PUNCT
ajbspi-37630	49	1	journal	journal	NOUN
ajbspi-37630	49	2	of	of	ADP
ajbspi-37630	49	3	pharmaceutical	pharmaceutical	NOUN
ajbspi-37630	49	4	sciences	science	NOUN
ajbspi-37630	49	5	,	,	PUNCT
ajbspi-37630	49	6	89(8	89(8	NUM
ajbspi-37630	49	7	)	)	PUNCT
ajbspi-37630	49	8	,	,	PUNCT
ajbspi-37630	49	9	967	967	NUM
ajbspi-37630	49	10	-	-	SYM
ajbspi-37630	49	11	978	978	NUM
ajbspi-37630	49	12	.	.	PUNCT
ajbspi-37630	50	1	2	2	NUM
ajbspi-37630	50	2	.	.	X
ajbspi-37630	50	3	dashevsky	dashevsky	PROPN
ajbspi-37630	50	4	,	,	PUNCT
ajbspi-37630	50	5	a.	a.	NOUN
ajbspi-37630	50	6	,	,	PUNCT
ajbspi-37630	50	7	tamaru	tamaru	NOUN
ajbspi-37630	50	8	,	,	PUNCT
ajbspi-37630	50	9	s.	s.	PROPN
ajbspi-37630	50	10	,	,	PUNCT
ajbspi-37630	50	11	&	&	CCONJ
ajbspi-37630	50	12	bolotin	bolotin	PROPN
ajbspi-37630	50	13	,	,	PUNCT
ajbspi-37630	50	14	e.	e.	PROPN
ajbspi-37630	50	15	(	(	PUNCT
ajbspi-37630	50	16	2009	2009	NUM
ajbspi-37630	50	17	)	)	PUNCT
ajbspi-37630	50	18	.	.	PUNCT
ajbspi-37630	51	1	fast	fast	ADV
ajbspi-37630	51	2	-	-	PUNCT
ajbspi-37630	51	3	dissolving	dissolve	VERB
ajbspi-37630	51	4	drug	drug	NOUN
ajbspi-37630	51	5	delivery	delivery	NOUN
ajbspi-37630	51	6	systems	system	NOUN
ajbspi-37630	51	7	:	:	PUNCT
ajbspi-37630	51	8	a	a	DET
ajbspi-37630	51	9	review	review	NOUN
ajbspi-37630	51	10	of	of	ADP
ajbspi-37630	51	11	the	the	DET
ajbspi-37630	51	12	literature	literature	NOUN
ajbspi-37630	51	13	.	.	PUNCT
ajbspi-37630	52	1	pharmaceutical	pharmaceutical	NOUN
ajbspi-37630	52	2	development	development	NOUN
ajbspi-37630	52	3	and	and	CCONJ
ajbspi-37630	52	4	technology	technology	NOUN
ajbspi-37630	52	5	,	,	PUNCT
ajbspi-37630	52	6	14(6	14(6	NOUN
ajbspi-37630	52	7	)	)	PUNCT
ajbspi-37630	52	8	,	,	PUNCT
ajbspi-37630	52	9	567	567	NUM
ajbspi-37630	52	10	-	-	SYM
ajbspi-37630	52	11	584	584	NUM
ajbspi-37630	52	12	.	.	NOUN
ajbspi-37630	53	1	3	3	X
ajbspi-37630	53	2	.	.	X
ajbspi-37630	53	3	gohel	gohel	PROPN
ajbspi-37630	53	4	,	,	PUNCT
ajbspi-37630	53	5	m.	m.	PROPN
ajbspi-37630	53	6	c.	c.	PROPN
ajbspi-37630	53	7	,	,	PUNCT
ajbspi-37630	53	8	&	&	CCONJ
ajbspi-37630	53	9	parikh	parikh	PROPN
ajbspi-37630	53	10	,	,	PUNCT
ajbspi-37630	53	11	r.	r.	PROPN
ajbspi-37630	53	12	k.	k.	PROPN
ajbspi-37630	54	1	(	(	PUNCT
ajbspi-37630	54	2	2011	2011	NUM
ajbspi-37630	54	3	)	)	PUNCT
ajbspi-37630	54	4	.	.	PUNCT
ajbspi-37630	55	1	fast	fast	ADJ
ajbspi-37630	55	2	dissolving	dissolve	VERB
ajbspi-37630	55	3	drug	drug	NOUN
ajbspi-37630	55	4	delivery	delivery	NOUN
ajbspi-37630	55	5	systems	system	NOUN
ajbspi-37630	55	6	:	:	PUNCT
ajbspi-37630	55	7	a	a	DET
ajbspi-37630	55	8	review	review	NOUN
ajbspi-37630	55	9	of	of	ADP
ajbspi-37630	55	10	the	the	DET
ajbspi-37630	55	11	literature	literature	NOUN
ajbspi-37630	55	12	.	.	PUNCT
ajbspi-37630	56	1	indian	indian	PROPN
ajbspi-37630	56	2	journal	journal	PROPN
ajbspi-37630	56	3	of	of	ADP
ajbspi-37630	56	4	pharmaceutical	pharmaceutical	NOUN
ajbspi-37630	56	5	sciences	science	NOUN
ajbspi-37630	56	6	,	,	PUNCT
ajbspi-37630	56	7	73(6	73(6	PROPN
ajbspi-37630	56	8	)	)	PUNCT
ajbspi-37630	56	9	,	,	PUNCT
ajbspi-37630	56	10	629	629	NUM
ajbspi-37630	56	11	-	-	SYM
ajbspi-37630	56	12	637	637	NUM
ajbspi-37630	56	13	.	.	PUNCT
ajbspi-37630	57	1	4	4	NUM
ajbspi-37630	57	2	.	.	X
ajbspi-37630	57	3	hussain	hussain	PROPN
ajbspi-37630	57	4	,	,	PUNCT
ajbspi-37630	57	5	a.	a.	PROPN
ajbspi-37630	57	6	,	,	PUNCT
ajbspi-37630	57	7	&	&	CCONJ
ajbspi-37630	57	8	singh	singh	PROPN
ajbspi-37630	57	9	,	,	PUNCT
ajbspi-37630	57	10	s.	s.	PROPN
ajbspi-37630	57	11	k.	k.	PROPN
ajbspi-37630	57	12	(	(	PUNCT
ajbspi-37630	57	13	2019	2019	NUM
ajbspi-37630	57	14	)	)	PUNCT
ajbspi-37630	57	15	.	.	PUNCT
ajbspi-37630	58	1	fast	fast	ADJ
ajbspi-37630	58	2	dissolving	dissolve	VERB
ajbspi-37630	58	3	tablets	tablet	NOUN
ajbspi-37630	58	4	:	:	PUNCT
ajbspi-37630	58	5	a	a	DET
ajbspi-37630	58	6	comprehensive	comprehensive	ADJ
ajbspi-37630	58	7	review	review	NOUN
ajbspi-37630	58	8	of	of	ADP
ajbspi-37630	58	9	formulation	formulation	NOUN
ajbspi-37630	58	10	and	and	CCONJ
ajbspi-37630	58	11	evaluation	evaluation	NOUN
ajbspi-37630	58	12	.	.	PUNCT
ajbspi-37630	59	1	journal	journal	NOUN
ajbspi-37630	59	2	of	of	ADP
ajbspi-37630	59	3	drug	drug	NOUN
ajbspi-37630	59	4	delivery	delivery	NOUN
ajbspi-37630	59	5	science	science	NOUN
ajbspi-37630	59	6	and	and	CCONJ
ajbspi-37630	59	7	technology	technology	NOUN
ajbspi-37630	59	8	,	,	PUNCT
ajbspi-37630	59	9	53	53	NUM
ajbspi-37630	59	10	,	,	PUNCT
ajbspi-37630	59	11	101186	101186	NUM
ajbspi-37630	59	12	.	.	PUNCT
ajbspi-37630	60	1	5	5	NUM
ajbspi-37630	60	2	.	.	X
ajbspi-37630	60	3	irfan	irfan	PROPN
ajbspi-37630	60	4	,	,	PUNCT
ajbspi-37630	60	5	m.	m.	NOUN
ajbspi-37630	60	6	,	,	PUNCT
ajbspi-37630	60	7	rabel	rabel	PROPN
ajbspi-37630	60	8	,	,	PUNCT
ajbspi-37630	60	9	s.	s.	PROPN
ajbspi-37630	60	10	,	,	PUNCT
ajbspi-37630	60	11	bukhtar	bukhtar	NOUN
ajbspi-37630	60	12	,	,	PUNCT
ajbspi-37630	60	13	q.	q.	PROPN
ajbspi-37630	60	14	,	,	PUNCT
ajbspi-37630	60	15	&	&	CCONJ
ajbspi-37630	60	16	qadir	qadir	PROPN
ajbspi-37630	60	17	,	,	PUNCT
ajbspi-37630	60	18	m.	m.	NOUN
ajbspi-37630	60	19	i.	i.	PROPN
ajbspi-37630	60	20	(	(	PUNCT
ajbspi-37630	60	21	2007	2007	NUM
ajbspi-37630	60	22	)	)	PUNCT
ajbspi-37630	60	23	.	.	PUNCT
ajbspi-37630	61	1	pharmaceutical	pharmaceutical	ADJ
ajbspi-37630	61	2	significance	significance	NOUN
ajbspi-37630	61	3	of	of	ADP
ajbspi-37630	61	4	superdisintegrants	superdisintegrant	NOUN
ajbspi-37630	61	5	in	in	ADP
ajbspi-37630	61	6	drug	drug	NOUN
ajbspi-37630	61	7	dissolution	dissolution	NOUN
ajbspi-37630	61	8	and	and	CCONJ
ajbspi-37630	61	9	absorption	absorption	NOUN
ajbspi-37630	61	10	enhancement	enhancement	NOUN
ajbspi-37630	61	11	.	.	PUNCT
ajbspi-37630	62	1	drug	drug	NOUN
ajbspi-37630	62	2	development	development	NOUN
ajbspi-37630	62	3	and	and	CCONJ
ajbspi-37630	62	4	industrial	industrial	ADJ
ajbspi-37630	62	5	pharmacy	pharmacy	NOUN
ajbspi-37630	62	6	,	,	PUNCT
ajbspi-37630	62	7	33(8	33(8	NUM
ajbspi-37630	62	8	)	)	PUNCT
ajbspi-37630	62	9	,	,	PUNCT
ajbspi-37630	62	10	913	913	NUM
ajbspi-37630	62	11	-	-	SYM
ajbspi-37630	62	12	924	924	NUM
ajbspi-37630	62	13	.	.	NOUN
ajbspi-37630	62	14	6	6	NUM
ajbspi-37630	62	15	.	.	X
ajbspi-37630	62	16	khan	khan	PROPN
ajbspi-37630	62	17	,	,	PUNCT
ajbspi-37630	62	18	k.	k.	PROPN
ajbspi-37630	62	19	a.	a.	PROPN
ajbspi-37630	62	20	(	(	PUNCT
ajbspi-37630	62	21	2005	2005	NUM
ajbspi-37630	62	22	)	)	PUNCT
ajbspi-37630	62	23	.	.	PUNCT
ajbspi-37630	63	1	the	the	DET
ajbspi-37630	63	2	concept	concept	NOUN
ajbspi-37630	63	3	of	of	ADP
ajbspi-37630	63	4	dissolution	dissolution	NOUN
ajbspi-37630	63	5	efficiency	efficiency	NOUN
ajbspi-37630	63	6	.	.	PUNCT
ajbspi-37630	64	1	journal	journal	NOUN
ajbspi-37630	64	2	of	of	ADP
ajbspi-37630	64	3	pharmacy	pharmacy	NOUN
ajbspi-37630	64	4	and	and	CCONJ
ajbspi-37630	64	5	pharmacology	pharmacology	NOUN
ajbspi-37630	64	6	,	,	PUNCT
ajbspi-37630	64	7	57(12	57(12	NUM
ajbspi-37630	64	8	)	)	PUNCT
ajbspi-37630	64	9	,	,	PUNCT
ajbspi-37630	64	10	1561	1561	NUM
ajbspi-37630	64	11	-	-	SYM
ajbspi-37630	64	12	1565	1565	NUM
ajbspi-37630	64	13	.	.	PUNCT
ajbspi-37630	65	1	7	7	X
ajbspi-37630	65	2	.	.	X
ajbspi-37630	65	3	tiwari	tiwari	PROPN
ajbspi-37630	65	4	,	,	PUNCT
ajbspi-37630	65	5	s.	s.	PROPN
ajbspi-37630	65	6	,	,	PUNCT
ajbspi-37630	65	7	pathak	pathak	PROPN
ajbspi-37630	65	8	,	,	PUNCT
ajbspi-37630	65	9	k.	k.	PROPN
ajbspi-37630	65	10	,	,	PUNCT
ajbspi-37630	65	11	&	&	CCONJ
ajbspi-37630	65	12	bali	bali	PROPN
ajbspi-37630	65	13	,	,	PUNCT
ajbspi-37630	65	14	v.	v.	PROPN
ajbspi-37630	65	15	(	(	PUNCT
ajbspi-37630	65	16	2012	2012	NUM
ajbspi-37630	65	17	)	)	PUNCT
ajbspi-37630	65	18	.	.	PUNCT
ajbspi-37630	66	1	fast	fast	ADJ
ajbspi-37630	66	2	dissolving	dissolve	VERB
ajbspi-37630	66	3	drug	drug	NOUN
ajbspi-37630	66	4	delivery	delivery	NOUN
ajbspi-37630	66	5	systems	system	NOUN
ajbspi-37630	66	6	:	:	PUNCT
ajbspi-37630	66	7	an	an	DET
ajbspi-37630	66	8	overview	overview	NOUN
ajbspi-37630	66	9	of	of	ADP
ajbspi-37630	66	10	the	the	DET
ajbspi-37630	66	11	formulation	formulation	NOUN
ajbspi-37630	66	12	strategies	strategy	NOUN
ajbspi-37630	66	13	.	.	PUNCT
ajbspi-37630	67	1	indian	indian	ADJ
ajbspi-37630	67	2	journal	journal	PROPN
ajbspi-37630	67	3	of	of	ADP
ajbspi-37630	67	4	pharmaceutical	pharmaceutical	NOUN
ajbspi-37630	67	5	sciences	science	NOUN
ajbspi-37630	67	6	,	,	PUNCT
ajbspi-37630	67	7	74(6	74(6	NOUN
ajbspi-37630	67	8	)	)	PUNCT
ajbspi-37630	67	9	,	,	PUNCT
ajbspi-37630	67	10	537	537	NUM
ajbspi-37630	67	11	-	-	SYM
ajbspi-37630	67	12	546	546	NUM
ajbspi-37630	67	13	.	.	NOUN
ajbspi-37630	67	14	8	8	NUM
ajbspi-37630	67	15	.	.	X
ajbspi-37630	68	1	zhou	zhou	PROPN
ajbspi-37630	68	2	,	,	PUNCT
ajbspi-37630	68	3	w.	w.	PROPN
ajbspi-37630	68	4	,	,	PUNCT
ajbspi-37630	68	5	li	li	PROPN
ajbspi-37630	68	6	,	,	PUNCT
ajbspi-37630	68	7	j.	j.	PROPN
ajbspi-37630	68	8	,	,	PUNCT
ajbspi-37630	68	9	li	li	PROPN
ajbspi-37630	68	10	,	,	PUNCT
ajbspi-37630	68	11	w.	w.	PROPN
ajbspi-37630	68	12	,	,	PUNCT
ajbspi-37630	68	13	liu	liu	PROPN
ajbspi-37630	68	14	,	,	PUNCT
ajbspi-37630	68	15	l.	l.	PROPN
ajbspi-37630	68	16	,	,	PUNCT
ajbspi-37630	68	17	&	&	CCONJ
ajbspi-37630	68	18	li	li	PROPN
ajbspi-37630	68	19	,	,	PUNCT
ajbspi-37630	68	20	s.	s.	PROPN
ajbspi-37630	68	21	(	(	PUNCT
ajbspi-37630	68	22	2019	2019	NUM
ajbspi-37630	68	23	)	)	PUNCT
ajbspi-37630	68	24	.	.	PUNCT
ajbspi-37630	69	1	recent	recent	ADJ
ajbspi-37630	69	2	advances	advance	NOUN
ajbspi-37630	69	3	in	in	ADP
ajbspi-37630	69	4	fast	fast	ADJ
ajbspi-37630	69	5	dissolving	dissolve	VERB
ajbspi-37630	69	6	tablets	tablet	NOUN
ajbspi-37630	69	7	:	:	PUNCT
ajbspi-37630	69	8	from	from	ADP
ajbspi-37630	69	9	formulation	formulation	NOUN
ajbspi-37630	69	10	development	development	NOUN
ajbspi-37630	69	11	to	to	ADP
ajbspi-37630	69	12	manufacturing	manufacturing	NOUN
ajbspi-37630	69	13	technologies	technology	NOUN
ajbspi-37630	69	14	.	.	PUNCT
ajbspi-37630	70	1	current	current	ADJ
ajbspi-37630	70	2	pharmaceutical	pharmaceutical	ADJ
ajbspi-37630	70	3	design	design	NOUN
ajbspi-37630	70	4	,	,	PUNCT
ajbspi-37630	70	5	25(23	25(23	NOUN
ajbspi-37630	70	6	)	)	PUNCT
ajbspi-37630	70	7	,	,	PUNCT
ajbspi-37630	70	8	2489	2489	NUM
ajbspi-37630	70	9	-	-	SYM
ajbspi-37630	70	10	2502	2502	NUM
ajbspi-37630	70	11	.	.	PUNCT
ajbspi-37630	71	1	https://doi.org/10.37547/ajbspi/volume03issue03-01	https://doi.org/10.37547/ajbspi/volume03issue03-01	PROPN
ajbspi-37630	71	2	https://scholar.google.co.in/scholar?q=	https://scholar.google.co.in/scholar?q=	PROPN
ajbspi-37630	71	3	https://www.mendeley.com/search/?page=1&query=	https://www.mendeley.com/search/?page=1&query=	NOUN